{
    "schema": "FN",
    "schema_version": "0.1.5",
    "name": "",
    "modules": [
        {
            "schema": "FN",
            "schema_version": "0.1.5",
            "name": "commented_Evaluation_Scenario_2.1.a.iii-Code_Version_B",
            "fn": {
                "b": [{"function_type":"MODULE","name":"module","metadata":2}],
                "bf": [
                    {"function_type":"EXPRESSION","contents":1,"metadata":4},
                    {"function_type":"EXPRESSION","contents":2,"metadata":6},
                    {"function_type":"EXPRESSION","contents":3,"metadata":8},
                    {"function_type":"EXPRESSION","contents":4,"metadata":10},
                    {"function_type":"EXPRESSION","contents":5,"metadata":19},
                    {"function_type":"PRIMITIVE","name":"pack"},
                    {"function_type":"EXPRESSION","contents":6,"metadata":21},
                    {"function_type":"EXPRESSION","contents":7,"metadata":23},
                    {"function_type":"EXPRESSION","contents":8,"metadata":25},
                    {"function_type":"FUNCTION","contents":9,"metadata":26},
                    {"function_type":"FUNCTION","contents":10,"metadata":27},
                    {"function_type":"EXPRESSION","contents":11,"metadata":29},
                    {"function_type":"FUNCTION","contents":12,"name":"module.plotSIDARTHE_0","metadata":30}
                ],
                "pif": [{"id":1,"box":6},{"id":2,"box":6},{"id":3,"box":6},{"id":4,"box":6},{"id":5,"box":6},{"id":6,"box":6},{"id":7,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":3,"box":7},{"id":4,"box":7},{"id":5,"box":7},{"id":6,"box":7},{"id":7,"box":7},{"id":8,"box":7},{"id":1,"box":11},{"id":2,"box":11},{"id":3,"box":11},{"id":1,"box":12},{"id":2,"box":12},{"id":3,"box":12},{"id":4,"box":12},{"id":1,"box":14},{"id":2,"box":14},{"id":3,"box":14},{"id":4,"box":14},{"id":5,"box":14},{"id":6,"box":14},{"id":7,"box":14},{"id":8,"box":14},{"id":9,"box":14}],
                "pof": [{"id":1,"name":"odeint","box":1},{"id":1,"name":"N0","box":2},{"id":1,"name":"T0","box":3},{"id":1,"name":"H0","box":4},{"id":1,"name":"E0","box":5},{"id":1,"name":"E","box":6},{"id":1,"name":"H","box":7},{"id":1,"name":"T","box":8},{"id":1,"name":"R","box":9},{"id":1,"name":"A","box":10},{"id":2,"name":"D","box":10},{"id":1,"name":"I","box":11},{"id":1,"name":"S","box":12,"metadata":28}],
                "wff": [{"src":1,"tgt":0},{"src":2,"tgt":0},{"src":3,"tgt":0},{"src":4,"tgt":0},{"src":5,"tgt":3},{"src":6,"tgt":4},{"src":7,"tgt":5},{"src":8,"tgt":6},{"src":9,"tgt":0},{"src":10,"tgt":0},{"src":11,"tgt":0},{"src":12,"tgt":0},{"src":13,"tgt":3},{"src":14,"tgt":4},{"src":15,"tgt":5},{"src":16,"tgt":9},{"src":17,"tgt":10},{"src":18,"tgt":8},{"src":19,"tgt":12},{"src":20,"tgt":7},{"src":21,"tgt":12},{"src":4,"tgt":12},{"src":23,"tgt":12},{"src":24,"tgt":13},{"src":25,"tgt":12},{"src":26,"tgt":11},{"src":27,"tgt":10},{"src":28,"tgt":9},{"src":29,"tgt":8},{"src":30,"tgt":7},{"src":31,"tgt":6}]
            },
            "attributes": [
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":1000000},"metadata":3}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":5}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":7}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":9}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1},{"id":7,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":1},"metadata":11},
                            {"function_type":"PRIMITIVE","name":"-","metadata":12},
                            {"function_type":"PRIMITIVE","name":"-","metadata":13},
                            {"function_type":"PRIMITIVE","name":"-","metadata":14},
                            {"function_type":"PRIMITIVE","name":"-","metadata":15},
                            {"function_type":"PRIMITIVE","name":"-","metadata":16},
                            {"function_type":"PRIMITIVE","name":"-","metadata":17},
                            {"function_type":"PRIMITIVE","name":"-","metadata":18}
                        ],
                        "pif": [{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":2,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":2,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":1,"box":8},{"id":2,"box":8}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8}],
                        "wfopi": [{"src":2,"tgt":1},{"src":4,"tgt":2},{"src":6,"tgt":3},{"src":8,"tgt":4},{"src":10,"tgt":5},{"src":12,"tgt":6},{"src":14,"tgt":7}],
                        "wff": [{"src":1,"tgt":1},{"src":3,"tgt":2},{"src":5,"tgt":3},{"src":7,"tgt":4},{"src":9,"tgt":5},{"src":11,"tgt":6},{"src":13,"tgt":7}],
                        "wfopo": [{"src":1,"tgt":8}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.5},"metadata":20}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":22}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":50},"metadata":24}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.arange",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "scipy.integrate.odeint",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":-1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"plotSIDARTHE","metadata":153}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":154},{"id":2,"name":"S","box":1,"metadata":155},{"id":3,"name":"I","box":1,"metadata":156},{"id":4,"name":"D","box":1,"metadata":157},{"id":5,"name":"A","box":1,"metadata":158},{"id":6,"name":"R","box":1,"metadata":159},{"id":7,"name":"T","box":1,"metadata":160},{"id":8,"name":"H","box":1,"metadata":161},{"id":9,"name":"E","box":1,"metadata":162}],
                        "bf": [
                            {"function_type":"IMPORTED_METHOD","name":"matplotlib.pyplot"},
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":1},"metadata":163},
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":1},"metadata":164},
                            {"function_type":"EXPRESSION","contents":39,"metadata":166},
                            {"function_type":"EXPRESSION","contents":40,"metadata":168},
                            {"function_type":"PRIMITIVE","name":"pack"},
                            {"function_type":"PRIMITIVE","name":"unpack"},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":355},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"b"},"metadata":171},
                            {"function_type":"EXPRESSION","contents":41,"metadata":173},
                            {"function_type":"EXPRESSION","contents":42,"metadata":175},
                            {"function_type":"EXPRESSION","contents":43,"metadata":177},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":356},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"r"},"metadata":178},
                            {"function_type":"EXPRESSION","contents":44,"metadata":180},
                            {"function_type":"EXPRESSION","contents":45,"metadata":182},
                            {"function_type":"EXPRESSION","contents":46,"metadata":184},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":357},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"r."},"metadata":185},
                            {"function_type":"EXPRESSION","contents":47,"metadata":187},
                            {"function_type":"EXPRESSION","contents":48,"metadata":189},
                            {"function_type":"EXPRESSION","contents":49,"metadata":191},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":358},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"r:"},"metadata":192},
                            {"function_type":"EXPRESSION","contents":50,"metadata":194},
                            {"function_type":"EXPRESSION","contents":51,"metadata":196},
                            {"function_type":"EXPRESSION","contents":52,"metadata":198},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":359},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"r--"},"metadata":199},
                            {"function_type":"EXPRESSION","contents":53,"metadata":201},
                            {"function_type":"EXPRESSION","contents":54,"metadata":203},
                            {"function_type":"EXPRESSION","contents":55,"metadata":205},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":360},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"r-."},"metadata":206},
                            {"function_type":"EXPRESSION","contents":56,"metadata":208},
                            {"function_type":"EXPRESSION","contents":57,"metadata":210},
                            {"function_type":"EXPRESSION","contents":58,"metadata":212},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":361},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"g"},"metadata":213},
                            {"function_type":"EXPRESSION","contents":59,"metadata":215},
                            {"function_type":"EXPRESSION","contents":60,"metadata":217},
                            {"function_type":"EXPRESSION","contents":61,"metadata":219},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":362},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"k"},"metadata":220},
                            {"function_type":"EXPRESSION","contents":62,"metadata":222},
                            {"function_type":"EXPRESSION","contents":63,"metadata":224},
                            {"function_type":"EXPRESSION","contents":64,"metadata":226},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":363},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Time (days)"},"metadata":227},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":364},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Fraction of population"},"metadata":228},
                            {"function_type":"EXPRESSION","contents":65,"metadata":230},
                            {"function_type":"EXPRESSION","contents":66,"metadata":232},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":365},
                            {"function_type":"EXPRESSION","contents":67,"metadata":234},
                            {"function_type":"EXPRESSION","contents":68,"metadata":236},
                            {"function_type":"EXPRESSION","contents":69,"metadata":238},
                            {"function_type":"EXPRESSION","contents":70,"metadata":240},
                            {"function_type":"EXPRESSION","contents":71,"metadata":242},
                            {"function_type":"IMPORTED_METHOD","name":"ax","metadata":366},
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.5},"metadata":243},
                            {"function_type":"IMPORTED_METHOD","name":"matplotlib.pyplot"}
                        ],
                        "pif": [{"id":1,"box":6},{"id":2,"box":6},{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":1,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":3,"box":8},{"id":4,"box":8},{"id":5,"box":8},{"id":6,"box":8},{"id":1,"box":13},{"id":2,"box":13},{"id":3,"box":13},{"id":4,"box":13},{"id":5,"box":13},{"id":6,"box":13},{"id":1,"box":18},{"id":2,"box":18},{"id":3,"box":18},{"id":4,"box":18},{"id":5,"box":18},{"id":6,"box":18},{"id":1,"box":23},{"id":2,"box":23},{"id":3,"box":23},{"id":4,"box":23},{"id":5,"box":23},{"id":6,"box":23},{"id":1,"box":28},{"id":2,"box":28},{"id":3,"box":28},{"id":4,"box":28},{"id":5,"box":28},{"id":6,"box":28},{"id":1,"box":33},{"id":2,"box":33},{"id":3,"box":33},{"id":4,"box":33},{"id":5,"box":33},{"id":6,"box":33},{"id":1,"box":38},{"id":2,"box":38},{"id":3,"box":38},{"id":4,"box":38},{"id":5,"box":38},{"id":6,"box":38},{"id":1,"box":43},{"id":2,"box":43},{"id":3,"box":43},{"id":4,"box":43},{"id":5,"box":43},{"id":6,"box":43},{"id":1,"box":48},{"id":1,"box":50},{"id":1,"box":51},{"id":1,"box":52},{"id":1,"box":54},{"id":2,"box":54},{"id":3,"box":54},{"id":4,"box":54},{"id":5,"box":54},{"id":1,"box":60}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"name":"figsize","box":6,"metadata":324},{"id":2,"box":6},{"id":1,"name":"f","box":7,"metadata":169},{"id":2,"name":"ax","box":7,"metadata":170},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"name":"alpha","box":10,"metadata":325},{"id":1,"name":"linewidth","box":11,"metadata":326},{"id":1,"name":"label","box":12,"metadata":327},{"id":1,"box":13},{"id":1,"box":14},{"id":1,"name":"alpha","box":15,"metadata":328},{"id":1,"name":"linewidth","box":16,"metadata":329},{"id":1,"name":"label","box":17,"metadata":330},{"id":1,"box":18},{"id":1,"box":19},{"id":1,"name":"alpha","box":20,"metadata":331},{"id":1,"name":"linewidth","box":21,"metadata":332},{"id":1,"name":"label","box":22,"metadata":333},{"id":1,"box":23},{"id":1,"box":24},{"id":1,"name":"alpha","box":25,"metadata":334},{"id":1,"name":"linewidth","box":26,"metadata":335},{"id":1,"name":"label","box":27,"metadata":336},{"id":1,"box":28},{"id":1,"box":29},{"id":1,"name":"alpha","box":30,"metadata":337},{"id":1,"name":"linewidth","box":31,"metadata":338},{"id":1,"name":"label","box":32,"metadata":339},{"id":1,"box":33},{"id":1,"box":34},{"id":1,"name":"alpha","box":35,"metadata":340},{"id":1,"name":"linewidth","box":36,"metadata":341},{"id":1,"name":"label","box":37,"metadata":342},{"id":1,"box":38},{"id":1,"box":39},{"id":1,"name":"alpha","box":40,"metadata":343},{"id":1,"name":"linewidth","box":41,"metadata":344},{"id":1,"name":"label","box":42,"metadata":345},{"id":1,"box":43},{"id":1,"box":44},{"id":1,"name":"alpha","box":45,"metadata":346},{"id":1,"name":"linewidth","box":46,"metadata":347},{"id":1,"name":"label","box":47,"metadata":348},{"id":1,"box":48},{"id":1,"box":49},{"id":1,"box":50},{"id":1,"box":51},{"id":1,"name":"length","box":52,"metadata":349},{"id":1,"name":"length","box":53,"metadata":350},{"id":1,"box":54},{"id":1,"name":"b","box":55,"metadata":351},{"id":1,"name":"which","box":56},{"id":1,"name":"c","box":57,"metadata":352},{"id":1,"name":"lw","box":58,"metadata":353},{"id":1,"name":"ls","box":59,"metadata":354},{"id":1,"box":60},{"id":1,"name":"legend","box":62},{"id":1,"name":"legend","box":63},{"id":1,"box":61},{"id":2,"box":62}],
                        "wfopi": [{"src":7,"tgt":1},{"src":8,"tgt":2},{"src":13,"tgt":1},{"src":14,"tgt":3},{"src":19,"tgt":1},{"src":20,"tgt":4},{"src":25,"tgt":1},{"src":26,"tgt":5},{"src":31,"tgt":1},{"src":32,"tgt":6},{"src":37,"tgt":1},{"src":38,"tgt":7},{"src":43,"tgt":1},{"src":44,"tgt":8},{"src":49,"tgt":1},{"src":50,"tgt":9}],
                        "wff": [{"src":1,"tgt":3},{"src":2,"tgt":4},{"src":3,"tgt":2},{"src":4,"tgt":3},{"src":5,"tgt":6},{"src":6,"tgt":7},{"src":9,"tgt":11},{"src":10,"tgt":12},{"src":11,"tgt":13},{"src":12,"tgt":14},{"src":15,"tgt":16},{"src":16,"tgt":17},{"src":17,"tgt":18},{"src":18,"tgt":19},{"src":21,"tgt":21},{"src":22,"tgt":22},{"src":23,"tgt":23},{"src":24,"tgt":24},{"src":27,"tgt":26},{"src":28,"tgt":27},{"src":29,"tgt":28},{"src":30,"tgt":29},{"src":33,"tgt":31},{"src":34,"tgt":32},{"src":35,"tgt":33},{"src":36,"tgt":34},{"src":39,"tgt":36},{"src":40,"tgt":37},{"src":41,"tgt":38},{"src":42,"tgt":39},{"src":45,"tgt":41},{"src":46,"tgt":42},{"src":47,"tgt":43},{"src":48,"tgt":44},{"src":51,"tgt":46},{"src":52,"tgt":47},{"src":53,"tgt":48},{"src":54,"tgt":49},{"src":55,"tgt":51},{"src":56,"tgt":53},{"src":57,"tgt":54},{"src":58,"tgt":55},{"src":59,"tgt":57},{"src":60,"tgt":58},{"src":61,"tgt":59},{"src":62,"tgt":60},{"src":63,"tgt":61},{"src":64,"tgt":65}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"SIDARTHE_model","metadata":31}],
                        "opi": [{"id":1,"name":"y","box":1,"metadata":32},{"id":2,"name":"t","box":1,"metadata":33},{"id":3,"name":"alpha","box":1,"metadata":34},{"id":4,"name":"beta","box":1,"metadata":35},{"id":5,"name":"gamma","box":1,"metadata":36},{"id":6,"name":"delta","box":1,"metadata":37},{"id":7,"name":"epsilon","box":1,"metadata":38},{"id":8,"name":"mu","box":1,"metadata":39},{"id":9,"name":"zeta","box":1,"metadata":40},{"id":10,"name":"lamb","box":1,"metadata":41},{"id":11,"name":"eta","box":1,"metadata":42},{"id":12,"name":"rho","box":1,"metadata":43},{"id":13,"name":"theta","box":1,"metadata":44},{"id":14,"name":"kappa","box":1,"metadata":45},{"id":15,"name":"nu","box":1,"metadata":46},{"id":16,"name":"xi","box":1,"metadata":47},{"id":17,"name":"sigma","box":1,"metadata":48},{"id":18,"name":"tau","box":1,"metadata":49}],
                        "opo": [{"id":1,"box":1,"metadata":151}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"\n    The SIDARTHE_model function calculates the derivatives of the model's state variables with respect to time.\n    \n    Parameters:\n    y (tuple of float): A tuple representing the current values of the state variables:\n       S - SUSCEPTIBLE\n       I - INFECTED\n       D - DIAGNOSED\n       A - AILING\n       R - RECOGNISED\n       T - THREATENED\n       H - HEALED\n       E - EXTINCT\n\n    t (float): The current time\n    \n    (function): \n        Functions representing the rates at which the state variables change\n    \n    Returns:\n    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)\n    "},"metadata":50},
                            {"function_type":"EXPRESSION","contents":14},
                            {"function_type":"PRIMITIVE","name":"unpack"},
                            {"function_type":"EXPRESSION","contents":19,"metadata":72},
                            {"function_type":"EXPRESSION","contents":23,"metadata":92},
                            {"function_type":"EXPRESSION","contents":26,"metadata":100},
                            {"function_type":"EXPRESSION","contents":30,"metadata":110},
                            {"function_type":"EXPRESSION","contents":33,"metadata":121},
                            {"function_type":"EXPRESSION","contents":36,"metadata":132},
                            {"function_type":"EXPRESSION","contents":37,"metadata":147},
                            {"function_type":"EXPRESSION","contents":38,"metadata":150},
                            {"function_type":"PRIMITIVE","name":"pack","metadata":152}
                        ],
                        "pif": [{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":3,"box":4},{"id":4,"box":4},{"id":5,"box":4},{"id":6,"box":4},{"id":7,"box":4},{"id":8,"box":4},{"id":9,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":3,"box":5},{"id":4,"box":5},{"id":5,"box":5},{"id":6,"box":5},{"id":7,"box":5},{"id":8,"box":5},{"id":9,"box":5},{"id":10,"box":5},{"id":1,"box":6},{"id":2,"box":6},{"id":3,"box":6},{"id":4,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":3,"box":7},{"id":4,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":3,"box":8},{"id":4,"box":8},{"id":5,"box":8},{"id":6,"box":8},{"id":1,"box":9},{"id":2,"box":9},{"id":3,"box":9},{"id":4,"box":9},{"id":5,"box":9},{"id":6,"box":9},{"id":1,"box":10},{"id":2,"box":10},{"id":3,"box":10},{"id":4,"box":10},{"id":5,"box":10},{"id":6,"box":10},{"id":7,"box":10},{"id":8,"box":10},{"id":9,"box":10},{"id":10,"box":10},{"id":1,"box":11},{"id":2,"box":11},{"id":1,"box":12},{"id":2,"box":12},{"id":3,"box":12},{"id":4,"box":12},{"id":5,"box":12},{"id":6,"box":12},{"id":7,"box":12},{"id":8,"box":12}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"name":"S","box":3,"metadata":51},{"id":2,"name":"I","box":3,"metadata":52},{"id":3,"name":"D","box":3,"metadata":53},{"id":4,"name":"A","box":3,"metadata":54},{"id":5,"name":"R","box":3,"metadata":55},{"id":6,"name":"T","box":3,"metadata":56},{"id":7,"name":"H","box":3,"metadata":57},{"id":8,"name":"E","box":3,"metadata":58},{"id":1,"name":"dSdt","box":4},{"id":1,"name":"dIdt","box":5,"metadata":367},{"id":1,"name":"dDdt","box":6,"metadata":368},{"id":1,"name":"dAdt","box":7,"metadata":369},{"id":1,"name":"dRdt","box":8,"metadata":370},{"id":1,"name":"dTdt","box":9,"metadata":371},{"id":1,"name":"dHdt","box":10,"metadata":372},{"id":1,"name":"dEdt","box":11},{"id":1,"box":12}],
                        "wfopi": [{"src":1,"tgt":1},{"src":4,"tgt":3},{"src":6,"tgt":4},{"src":8,"tgt":5},{"src":10,"tgt":6},{"src":12,"tgt":3},{"src":14,"tgt":4},{"src":16,"tgt":5},{"src":18,"tgt":6},{"src":21,"tgt":7},{"src":22,"tgt":7},{"src":24,"tgt":11},{"src":26,"tgt":9},{"src":28,"tgt":13},{"src":30,"tgt":11},{"src":32,"tgt":13},{"src":34,"tgt":15},{"src":36,"tgt":8},{"src":38,"tgt":15},{"src":40,"tgt":17},{"src":42,"tgt":10},{"src":44,"tgt":12},{"src":46,"tgt":14},{"src":48,"tgt":16},{"src":50,"tgt":17},{"src":52,"tgt":18}],
                        "wff": [{"src":2,"tgt":2},{"src":3,"tgt":3},{"src":5,"tgt":4},{"src":7,"tgt":5},{"src":9,"tgt":6},{"src":11,"tgt":7},{"src":13,"tgt":4},{"src":15,"tgt":5},{"src":17,"tgt":6},{"src":19,"tgt":7},{"src":20,"tgt":3},{"src":23,"tgt":4},{"src":25,"tgt":5},{"src":27,"tgt":4},{"src":29,"tgt":6},{"src":31,"tgt":5},{"src":33,"tgt":6},{"src":35,"tgt":7},{"src":37,"tgt":6},{"src":39,"tgt":7},{"src":41,"tgt":8},{"src":43,"tgt":4},{"src":45,"tgt":5},{"src":47,"tgt":6},{"src":49,"tgt":7},{"src":51,"tgt":8},{"src":53,"tgt":8},{"src":54,"tgt":11},{"src":55,"tgt":12},{"src":56,"tgt":13},{"src":57,"tgt":14},{"src":58,"tgt":15},{"src":59,"tgt":16},{"src":60,"tgt":17},{"src":61,"tgt":18}],
                        "wfopo": [{"src":1,"tgt":19}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "wopio": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"alpha","metadata":244}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":245}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":72,"metadata":246},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":93,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":95,"row_end":95}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":95,"row_end":95}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":95,"row_end":95}]}]},"metadata":247},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.75,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":50,"row_start":95,"row_end":95}]}]},"metadata":248}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"beta","metadata":249}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":250}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":73,"metadata":251},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":95,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":38,"row_start":96,"row_end":96}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":40,"col_end":41,"row_start":96,"row_end":96}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":41,"row_start":96,"row_end":96}]}]},"metadata":252},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.1,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":45,"col_end":48,"row_start":96,"row_end":96}]}]},"metadata":253}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"gamma","metadata":259}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":260}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":75,"metadata":261},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":97,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":98,"row_end":98}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":98,"row_end":98}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":98,"row_end":98}]}]},"metadata":262},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.2,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":49,"row_start":98,"row_end":98}]}]},"metadata":263}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"delta","metadata":254}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":255}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":74,"metadata":256},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":96,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":97,"row_end":97}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":97,"row_end":97}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":97,"row_end":97}]}]},"metadata":257},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":50,"row_start":97,"row_end":97}]}]},"metadata":258}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1},{"id":7,"box":1},{"id":8,"box":1},{"id":9,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"PRIMITIVE","name":"USub","metadata":59},
                            {"function_type":"FUNCTION","contents":15,"name":"module.SIDARTHE_model_id17.alpha_0","metadata":60},
                            {"function_type":"PRIMITIVE","name":"*","metadata":61},
                            {"function_type":"FUNCTION","contents":16,"name":"module.SIDARTHE_model_id17.beta_0","metadata":62},
                            {"function_type":"PRIMITIVE","name":"*","metadata":63},
                            {"function_type":"PRIMITIVE","name":"+","metadata":64},
                            {"function_type":"FUNCTION","contents":17,"name":"module.SIDARTHE_model_id17.gamma_0","metadata":65},
                            {"function_type":"PRIMITIVE","name":"*","metadata":66},
                            {"function_type":"PRIMITIVE","name":"+","metadata":67},
                            {"function_type":"FUNCTION","contents":18,"name":"module.SIDARTHE_model_id17.delta_0","metadata":68},
                            {"function_type":"PRIMITIVE","name":"*","metadata":69},
                            {"function_type":"PRIMITIVE","name":"+","metadata":70},
                            {"function_type":"PRIMITIVE","name":"*","metadata":71}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":2,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":2,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":2,"box":9},{"id":1,"box":10},{"id":1,"box":11},{"id":2,"box":11},{"id":1,"box":12},{"id":2,"box":12},{"id":1,"box":13},{"id":2,"box":13}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"box":10},{"id":1,"box":11},{"id":1,"box":12},{"id":1,"box":13}],
                        "wfopi": [{"src":1,"tgt":1},{"src":2,"tgt":2},{"src":3,"tgt":2},{"src":4,"tgt":3},{"src":5,"tgt":2},{"src":6,"tgt":4},{"src":7,"tgt":5},{"src":10,"tgt":2},{"src":11,"tgt":6},{"src":12,"tgt":7},{"src":15,"tgt":2},{"src":16,"tgt":8},{"src":17,"tgt":9}],
                        "wff": [{"src":8,"tgt":3},{"src":9,"tgt":5},{"src":13,"tgt":6},{"src":14,"tgt":8},{"src":18,"tgt":9},{"src":19,"tgt":11},{"src":20,"tgt":1},{"src":21,"tgt":12}],
                        "wfopo": [{"src":1,"tgt":13}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"epsilon","metadata":264}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":265}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":76,"metadata":266},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":98,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":40,"col_end":41,"row_start":100,"row_end":100}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":43,"col_end":44,"row_start":100,"row_end":100}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":40,"col_end":44,"row_start":100,"row_end":100}]}]},"metadata":267},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.1,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":48,"col_end":51,"row_start":100,"row_end":100}]}]},"metadata":268}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"zeta","metadata":274}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":275}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":78,"metadata":276},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":100,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":38,"row_start":103,"row_end":103}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":40,"col_end":41,"row_start":103,"row_end":103}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":41,"row_start":103,"row_end":103}]}]},"metadata":277},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":45,"col_end":49,"row_start":103,"row_end":103}]}]},"metadata":278}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"lamb","metadata":294}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":295}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":82,"metadata":296},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":104,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":38,"row_start":108,"row_end":108}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":40,"col_end":41,"row_start":108,"row_end":108}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":37,"col_end":41,"row_start":108,"row_end":108}]}]},"metadata":297},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":45,"col_end":49,"row_start":108,"row_end":108}]}]},"metadata":298}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1},{"id":7,"box":1},{"id":8,"box":1},{"id":9,"box":1},{"id":10,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":15,"name":"module.SIDARTHE_model_id17.alpha_1","metadata":73},
                            {"function_type":"PRIMITIVE","name":"*","metadata":74},
                            {"function_type":"FUNCTION","contents":16,"name":"module.SIDARTHE_model_id17.beta_1","metadata":75},
                            {"function_type":"PRIMITIVE","name":"*","metadata":76},
                            {"function_type":"PRIMITIVE","name":"+","metadata":77},
                            {"function_type":"FUNCTION","contents":17,"name":"module.SIDARTHE_model_id17.gamma_1","metadata":78},
                            {"function_type":"PRIMITIVE","name":"*","metadata":79},
                            {"function_type":"PRIMITIVE","name":"+","metadata":80},
                            {"function_type":"FUNCTION","contents":18,"name":"module.SIDARTHE_model_id17.delta_1","metadata":81},
                            {"function_type":"PRIMITIVE","name":"*","metadata":82},
                            {"function_type":"PRIMITIVE","name":"+","metadata":83},
                            {"function_type":"PRIMITIVE","name":"*","metadata":84},
                            {"function_type":"FUNCTION","contents":20,"name":"module.SIDARTHE_model_id17.epsilon_0","metadata":85},
                            {"function_type":"FUNCTION","contents":21,"name":"module.SIDARTHE_model_id17.zeta_0","metadata":86},
                            {"function_type":"PRIMITIVE","name":"+","metadata":87},
                            {"function_type":"FUNCTION","contents":22,"name":"module.SIDARTHE_model_id17.lamb_0","metadata":88},
                            {"function_type":"PRIMITIVE","name":"+","metadata":89},
                            {"function_type":"PRIMITIVE","name":"*","metadata":90},
                            {"function_type":"PRIMITIVE","name":"-","metadata":91}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":1,"box":10},{"id":2,"box":10},{"id":1,"box":11},{"id":2,"box":11},{"id":1,"box":12},{"id":2,"box":12},{"id":1,"box":13},{"id":1,"box":14},{"id":1,"box":15},{"id":2,"box":15},{"id":1,"box":16},{"id":1,"box":17},{"id":2,"box":17},{"id":1,"box":18},{"id":2,"box":18},{"id":1,"box":19},{"id":2,"box":19}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"box":10},{"id":1,"box":11},{"id":1,"box":12},{"id":1,"box":13},{"id":1,"box":14},{"id":1,"box":15},{"id":1,"box":16},{"id":1,"box":17},{"id":1,"box":18},{"id":1,"box":19}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":3},{"src":6,"tgt":4},{"src":9,"tgt":2},{"src":10,"tgt":5},{"src":11,"tgt":6},{"src":14,"tgt":2},{"src":15,"tgt":7},{"src":16,"tgt":8},{"src":19,"tgt":9},{"src":21,"tgt":2},{"src":22,"tgt":2},{"src":23,"tgt":10},{"src":25,"tgt":2},{"src":29,"tgt":2}],
                        "wff": [{"src":7,"tgt":2},{"src":8,"tgt":4},{"src":12,"tgt":5},{"src":13,"tgt":7},{"src":17,"tgt":8},{"src":18,"tgt":10},{"src":20,"tgt":11},{"src":24,"tgt":14},{"src":26,"tgt":15},{"src":27,"tgt":16},{"src":28,"tgt":17},{"src":30,"tgt":12},{"src":31,"tgt":18}],
                        "wfopo": [{"src":1,"tgt":19}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"eta","metadata":279}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":280}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":79,"metadata":281},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":101,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":37,"row_start":104,"row_end":104}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":39,"col_end":40,"row_start":104,"row_end":104}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":40,"row_start":104,"row_end":104}]}]},"metadata":282},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":44,"col_end":48,"row_start":104,"row_end":104}]}]},"metadata":283}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"rho","metadata":299}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":300}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":83,"metadata":301},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":105,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":37,"row_start":109,"row_end":109}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":39,"col_end":40,"row_start":109,"row_end":109}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":40,"row_start":109,"row_end":109}]}]},"metadata":302},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":44,"col_end":48,"row_start":109,"row_end":109}]}]},"metadata":303}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":20,"name":"module.SIDARTHE_model_id17.epsilon_1","metadata":93},
                            {"function_type":"PRIMITIVE","name":"*","metadata":94},
                            {"function_type":"FUNCTION","contents":24,"name":"module.SIDARTHE_model_id17.eta_0","metadata":95},
                            {"function_type":"FUNCTION","contents":25,"name":"module.SIDARTHE_model_id17.rho_0","metadata":96},
                            {"function_type":"PRIMITIVE","name":"+","metadata":97},
                            {"function_type":"PRIMITIVE","name":"*","metadata":98},
                            {"function_type":"PRIMITIVE","name":"-","metadata":99}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":2,"box":6},{"id":1,"box":7},{"id":2,"box":7}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":2},{"src":6,"tgt":3},{"src":9,"tgt":4}],
                        "wff": [{"src":7,"tgt":4},{"src":8,"tgt":5},{"src":10,"tgt":2},{"src":11,"tgt":6}],
                        "wfopo": [{"src":1,"tgt":7}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"theta","metadata":269}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":270}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":77,"metadata":271},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":99,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":101,"row_end":101}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":101,"row_end":101}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":101,"row_end":101}]}]},"metadata":272},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.1,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":49,"row_start":101,"row_end":101}]}]},"metadata":273}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"mu","metadata":284}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":285}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":80,"metadata":286},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":102,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":36,"row_start":106,"row_end":106}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":106,"row_end":106}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":39,"row_start":106,"row_end":106}]}]},"metadata":287},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":43,"col_end":47,"row_start":106,"row_end":106}]}]},"metadata":288}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"kappa","metadata":304}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":305}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":84,"metadata":306},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":106,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":111,"row_end":111}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":111,"row_end":111}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":111,"row_end":111}]}]},"metadata":307},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.01,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":50,"row_start":111,"row_end":111}]}]},"metadata":308}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":21,"name":"module.SIDARTHE_model_id17.zeta_1","metadata":101},
                            {"function_type":"PRIMITIVE","name":"*","metadata":102},
                            {"function_type":"FUNCTION","contents":27,"name":"module.SIDARTHE_model_id17.theta_0","metadata":103},
                            {"function_type":"FUNCTION","contents":28,"name":"module.SIDARTHE_model_id17.mu_0","metadata":104},
                            {"function_type":"PRIMITIVE","name":"+","metadata":105},
                            {"function_type":"FUNCTION","contents":29,"name":"module.SIDARTHE_model_id17.kappa_0","metadata":106},
                            {"function_type":"PRIMITIVE","name":"+","metadata":107},
                            {"function_type":"PRIMITIVE","name":"*","metadata":108},
                            {"function_type":"PRIMITIVE","name":"-","metadata":109}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":2,"box":9}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":2},{"src":6,"tgt":3},{"src":8,"tgt":2},{"src":12,"tgt":4}],
                        "wff": [{"src":7,"tgt":4},{"src":9,"tgt":5},{"src":10,"tgt":6},{"src":11,"tgt":7},{"src":13,"tgt":2},{"src":14,"tgt":8}],
                        "wfopo": [{"src":1,"tgt":9}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"nu","metadata":289}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":290}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":81,"metadata":291},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":103,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":36,"row_start":107,"row_end":107}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":107,"row_end":107}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":39,"row_start":107,"row_end":107}]}]},"metadata":292},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.05,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":43,"col_end":47,"row_start":107,"row_end":107}]}]},"metadata":293}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"xi","metadata":309}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":310}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":85,"metadata":311},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":107,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":36,"row_start":112,"row_end":112}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":112,"row_end":112}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":35,"col_end":39,"row_start":112,"row_end":112}]}]},"metadata":312},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.01,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":43,"col_end":47,"row_start":112,"row_end":112}]}]},"metadata":313}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":24,"name":"module.SIDARTHE_model_id17.eta_1","metadata":111},
                            {"function_type":"PRIMITIVE","name":"*","metadata":112},
                            {"function_type":"FUNCTION","contents":27,"name":"module.SIDARTHE_model_id17.theta_1","metadata":113},
                            {"function_type":"PRIMITIVE","name":"*","metadata":114},
                            {"function_type":"PRIMITIVE","name":"+","metadata":115},
                            {"function_type":"FUNCTION","contents":31,"name":"module.SIDARTHE_model_id17.nu_0","metadata":116},
                            {"function_type":"FUNCTION","contents":32,"name":"module.SIDARTHE_model_id17.xi_0","metadata":117},
                            {"function_type":"PRIMITIVE","name":"+","metadata":118},
                            {"function_type":"PRIMITIVE","name":"*","metadata":119},
                            {"function_type":"PRIMITIVE","name":"-","metadata":120}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":2,"box":9},{"id":1,"box":10},{"id":2,"box":10}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"box":10}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":3},{"src":6,"tgt":4},{"src":9,"tgt":2},{"src":10,"tgt":2},{"src":11,"tgt":5},{"src":14,"tgt":6}],
                        "wff": [{"src":7,"tgt":2},{"src":8,"tgt":4},{"src":12,"tgt":7},{"src":13,"tgt":8},{"src":15,"tgt":5},{"src":16,"tgt":9}],
                        "wfopo": [{"src":1,"tgt":10}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"sigma","metadata":314}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":315}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":86,"metadata":316},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":108,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":39,"row_start":113,"row_end":113}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":41,"col_end":42,"row_start":113,"row_end":113}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":38,"col_end":42,"row_start":113,"row_end":113}]}]},"metadata":317},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.01,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":46,"col_end":50,"row_start":113,"row_end":113}]}]},"metadata":318}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"FUNCTION","name":"tau","metadata":319}],
                        "opi": [{"id":1,"name":"t","box":1,"metadata":320}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":87,"metadata":321},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"op":"Gte","left":{"name":"t","id":109,"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":37,"row_start":115,"row_end":115}]},"right":{"value_type":"Integer","value":0,"source_code_data_type":["Python","3.8","<class 'int'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":39,"col_end":40,"row_start":115,"row_end":115}]},"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":36,"col_end":40,"row_start":115,"row_end":115}]}]},"metadata":322},
                            {"function_type":"LITERAL","value":{"value_type":"List","value":[{"value_type":"AbstractFloat","value":0.01,"source_code_data_type":["Python","3.8","<class 'float'>"],"source_refs":[{"source_file_name":"commented_Evaluation_Scenario_2","col_start":44,"col_end":48,"row_start":115,"row_end":115}]}]},"metadata":323}
                        ],
                        "pif": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1}],
                        "pof": [{"id":1,"box":2},{"id":1,"box":3}],
                        "wfopi": [{"src":1,"tgt":1}],
                        "wff": [{"src":2,"tgt":1},{"src":3,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":28,"name":"module.SIDARTHE_model_id17.mu_1","metadata":122},
                            {"function_type":"PRIMITIVE","name":"*","metadata":123},
                            {"function_type":"FUNCTION","contents":31,"name":"module.SIDARTHE_model_id17.nu_1","metadata":124},
                            {"function_type":"PRIMITIVE","name":"*","metadata":125},
                            {"function_type":"PRIMITIVE","name":"+","metadata":126},
                            {"function_type":"FUNCTION","contents":34,"name":"module.SIDARTHE_model_id17.sigma_0","metadata":127},
                            {"function_type":"FUNCTION","contents":35,"name":"module.SIDARTHE_model_id17.tau_0","metadata":128},
                            {"function_type":"PRIMITIVE","name":"+","metadata":129},
                            {"function_type":"PRIMITIVE","name":"*","metadata":130},
                            {"function_type":"PRIMITIVE","name":"-","metadata":131}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":2,"box":9},{"id":1,"box":10},{"id":2,"box":10}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"box":10}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":3},{"src":6,"tgt":4},{"src":9,"tgt":2},{"src":10,"tgt":2},{"src":11,"tgt":5},{"src":14,"tgt":6}],
                        "wff": [{"src":7,"tgt":2},{"src":8,"tgt":4},{"src":12,"tgt":7},{"src":13,"tgt":8},{"src":15,"tgt":5},{"src":16,"tgt":9}],
                        "wfopo": [{"src":1,"tgt":10}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1},{"id":3,"box":1},{"id":4,"box":1},{"id":5,"box":1},{"id":6,"box":1},{"id":7,"box":1},{"id":8,"box":1},{"id":9,"box":1},{"id":10,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":22,"name":"module.SIDARTHE_model_id17.lamb_1","metadata":133},
                            {"function_type":"PRIMITIVE","name":"*","metadata":134},
                            {"function_type":"FUNCTION","contents":25,"name":"module.SIDARTHE_model_id17.rho_1","metadata":135},
                            {"function_type":"PRIMITIVE","name":"*","metadata":136},
                            {"function_type":"PRIMITIVE","name":"+","metadata":137},
                            {"function_type":"FUNCTION","contents":29,"name":"module.SIDARTHE_model_id17.kappa_1","metadata":138},
                            {"function_type":"PRIMITIVE","name":"*","metadata":139},
                            {"function_type":"PRIMITIVE","name":"+","metadata":140},
                            {"function_type":"FUNCTION","contents":32,"name":"module.SIDARTHE_model_id17.xi_1","metadata":141},
                            {"function_type":"PRIMITIVE","name":"*","metadata":142},
                            {"function_type":"PRIMITIVE","name":"+","metadata":143},
                            {"function_type":"FUNCTION","contents":34,"name":"module.SIDARTHE_model_id17.sigma_1","metadata":144},
                            {"function_type":"PRIMITIVE","name":"*","metadata":145},
                            {"function_type":"PRIMITIVE","name":"+","metadata":146}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":2,"box":4},{"id":1,"box":5},{"id":2,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":2,"box":7},{"id":1,"box":8},{"id":2,"box":8},{"id":1,"box":9},{"id":1,"box":10},{"id":2,"box":10},{"id":1,"box":11},{"id":2,"box":11},{"id":1,"box":12},{"id":1,"box":13},{"id":2,"box":13},{"id":1,"box":14},{"id":2,"box":14}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2},{"id":1,"box":3},{"id":1,"box":4},{"id":1,"box":5},{"id":1,"box":6},{"id":1,"box":7},{"id":1,"box":8},{"id":1,"box":9},{"id":1,"box":10},{"id":1,"box":11},{"id":1,"box":12},{"id":1,"box":13},{"id":1,"box":14}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2},{"src":4,"tgt":2},{"src":5,"tgt":3},{"src":6,"tgt":4},{"src":9,"tgt":2},{"src":10,"tgt":5},{"src":11,"tgt":6},{"src":14,"tgt":2},{"src":15,"tgt":7},{"src":16,"tgt":8},{"src":19,"tgt":2},{"src":20,"tgt":9},{"src":21,"tgt":10}],
                        "wff": [{"src":7,"tgt":2},{"src":8,"tgt":4},{"src":12,"tgt":5},{"src":13,"tgt":7},{"src":17,"tgt":8},{"src":18,"tgt":10},{"src":22,"tgt":11},{"src":23,"tgt":13}],
                        "wfopo": [{"src":1,"tgt":14}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opi": [{"id":1,"box":1},{"id":2,"box":1}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"FUNCTION","contents":35,"name":"module.SIDARTHE_model_id17.tau_1","metadata":148},
                            {"function_type":"PRIMITIVE","name":"*","metadata":149}
                        ],
                        "pif": [{"id":1,"box":1},{"id":1,"box":2},{"id":2,"box":2}],
                        "pof": [{"id":1,"box":1},{"id":1,"box":2}],
                        "wfopi": [{"src":1,"tgt":2},{"src":2,"tgt":1},{"src":3,"tgt":2}],
                        "wfopo": [{"src":1,"tgt":2}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":10},"metadata":165}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":4},"metadata":167}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":172}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":174}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Susceptible"},"metadata":176}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":179}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":181}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Infected (Asymptomatic, Infected, Undetected)"},"metadata":183}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":186}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":188}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Diagnosed (Asymptomatic, Infected, Detected)"},"metadata":190}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":193}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":195}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Ailing (Symptomatic, Infected, Undetected)"},"metadata":197}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":200}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":202}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Recognized (Symptomatic, Infected, Detected)"},"metadata":204}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":207}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":209}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Threatened (Acutely Symptomatic)"},"metadata":211}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":214}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":216}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Healed"},"metadata":218}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"AbstractFloat","value":0.7},"metadata":221}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":223}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"Extinct (Dead)"},"metadata":225}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":229}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":0},"metadata":231}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":true},"metadata":233}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"major"},"metadata":235}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"w"},"metadata":237}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"Integer","value":2},"metadata":239}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "FN",
                    "value": {
                        "b": [{"function_type":"EXPRESSION"}],
                        "opo": [{"id":1,"box":1}],
                        "bf": [
                            {"function_type":"LITERAL","value":{"value_type":"List","value":"-"},"metadata":241}
                        ],
                        "pof": [{"id":1,"box":1}],
                        "wfopo": [{"src":1,"tgt":1}]
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                },
                {
                    "type": "IMPORT",
                    "value": {
                        "name": "numpy.piecewise",
                        "src_language": "Python",
                        "type": "OTHER",
                        "version": "3.8"
                    }
                }
            ],
            "metadata_collection": [
                [
                    {"metadata_type":"source_code_collection","name":"","global_reference_id":"","files":[{"uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","name":"commented_Evaluation_Scenario_2.1.a.iii-Code_Version_B.py","path":""}],"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489234"}},
                    {"metadata_type":"gromet_creation","gromet_version":"0.1.5","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489256"}},
                    {"metadata_type":"textual_document_collection","documents":[{"uid":"5eeeebb4a58f1dfd5209aecc.pdf","global_reference_id":"TBD","cosmos_id":"5eeeebb4a58f1dfd5209aecc.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5eecd54fa58f1dfd52099ccf.pdf","global_reference_id":"TBD","cosmos_id":"5eecd54fa58f1dfd52099ccf.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"616cf16267467f7269ccde6f.pdf","global_reference_id":"TBD","cosmos_id":"616cf16267467f7269ccde6f.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"60a7e9813f2ac7e701375253.pdf","global_reference_id":"TBD","cosmos_id":"60a7e9813f2ac7e701375253.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"60e7da3067467f7269c05e30.pdf","global_reference_id":"TBD","cosmos_id":"60e7da3067467f7269c05e30.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5ecbc3c4768935d2be5bd0e2.pdf","global_reference_id":"TBD","cosmos_id":"5ecbc3c4768935d2be5bd0e2.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"6021463eea8bd37226de0b5e.pdf","global_reference_id":"TBD","cosmos_id":"6021463eea8bd37226de0b5e.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"616e3bd867467f7269d2f250.pdf","global_reference_id":"TBD","cosmos_id":"616e3bd867467f7269d2f250.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5ed7bd5b768935d2be5cd1df.pdf","global_reference_id":"TBD","cosmos_id":"5ed7bd5b768935d2be5cd1df.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5f21d319a58f1dfd5210565c.pdf","global_reference_id":"TBD","cosmos_id":"5f21d319a58f1dfd5210565c.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5ee22d2e725b01fb00406d54.pdf","global_reference_id":"TBD","cosmos_id":"5ee22d2e725b01fb00406d54.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5f2d7604a58f1dfd5210abe5.pdf","global_reference_id":"TBD","cosmos_id":"5f2d7604a58f1dfd5210abe5.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"621eee202688b71135317157.pdf","global_reference_id":"TBD","cosmos_id":"621eee202688b71135317157.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"61a3d8d567467f7269520df0.pdf","global_reference_id":"TBD","cosmos_id":"61a3d8d567467f7269520df0.pdf","cosmos_version_number":0.1,"skema_id":0.1},{"uid":"5f525fefa58f1dfd521414f8.pdf","global_reference_id":"TBD","cosmos_id":"5f525fefa58f1dfd521414f8.pdf","cosmos_version_number":0.1,"skema_id":0.1}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":1,"line_end":134,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489274"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489411"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":118,"line_end":118,"col_begin":5,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489404"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":118,"line_end":118,"col_begin":0,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489378"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489501"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":55,"col_end":56,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489495"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":0,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489472"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489549"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":58,"col_end":59,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489543"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":0,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489472"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489597"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":61,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489590"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":119,"line_end":119,"col_begin":0,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489472"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489700"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":6,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489692"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489724"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":12,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489769"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":15,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489825"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489864"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490003"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":24,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490043"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":5,"col_end":27,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490083"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":120,"line_end":120,"col_begin":0,"col_end":27,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.489647"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490279"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":124,"line_end":124,"col_begin":5,"col_end":7,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490273"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":124,"line_end":124,"col_begin":0,"col_end":7,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490254"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490344"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":125,"line_end":125,"col_begin":9,"col_end":10,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490338"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":125,"line_end":125,"col_begin":0,"col_end":10,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490320"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490406"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":126,"line_end":126,"col_begin":7,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490400"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":126,"line_end":126,"col_begin":0,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490383"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":127,"line_end":127,"col_begin":8,"col_end":17,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490521"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":130,"line_end":130,"col_begin":6,"col_end":142,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490688"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":130,"line_end":130,"col_begin":0,"col_end":3,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490763"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":131,"line_end":131,"col_begin":0,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490832"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":134,"line_end":134,"col_begin":0,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.490895"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":64,"col_begin":0,"col_end":57,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491103"}},
                    {"metadata_type":"source_code_comment","comment":" Initialize variables S, I, D, A, R, T, H, E from the input y","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":36,"line_end":36,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in susceptible population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":39,"line_end":39,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in infected population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":42,"line_end":42,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in detected population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":45,"line_end":45,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in asymptomatic population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":48,"line_end":48,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in recovered population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":51,"line_end":51,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in treated population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":54,"line_end":54,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in hospitalized population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":57,"line_end":57,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Calculate the change in deceased population over time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":60,"line_end":60,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":" Return the changes in each population as a tuple","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":63,"line_end":63,"provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    The SIDARTHE_model function calculates the derivatives of the model's state variables with respect to time.","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    ","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    Parameters:","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    y (tuple of float): A tuple representing the current values of the state variables:","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       S - SUSCEPTIBLE","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       I - INFECTED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       D - DIAGNOSED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       A - AILING","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       R - RECOGNISED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       T - THREATENED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       H - HEALED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       E - EXTINCT","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    t (float): The current time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    ","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    (function): ","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"        Functions representing the rates at which the state variables change","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    ","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    Returns:","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    ","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":19,"col_end":20,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491127"}},
                    {"metadata_type":"source_code_comment","comment":"    y (tuple of float): A tuple representing the current values of the state variables:","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":22,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491149"}},
                    {"metadata_type":"source_code_comment","comment":"    t (float): The current time","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":25,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491170"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":32,"col_end":36,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491235"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":38,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491256"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":45,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491276"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":52,"col_end":59,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491447"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":61,"col_end":63,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491548"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":65,"col_end":69,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491577"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":71,"col_end":75,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491600"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":77,"col_end":80,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491622"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":82,"col_end":85,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491645"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":87,"col_end":92,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491666"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":94,"col_end":99,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491688"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":101,"col_end":103,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491709"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":105,"col_end":107,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491731"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":109,"col_end":114,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491755"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":12,"line_end":12,"col_begin":116,"col_end":119,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491778"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491810"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":13,"line_end":34,"col_begin":4,"col_end":7,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491803"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":4,"col_end":5,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491870"}},
                    {"metadata_type":"source_code_comment","comment":"       S - SUSCEPTIBLE","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":339,"char_end":356},"variable_identifier":"SIHRD model n","value":{"value":"5"},"grounding":[{"argument_name":"variable","id":"apollosv:00000551","description":"Susceptible-Exposed-Infectious-Recovered model","score":0.7602279},{"argument_name":"variable","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.7125074},{"argument_name":"variable","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.6826137},{"argument_name":"variable","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.6722575},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.6373796}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":7,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491885"}},
                    {"metadata_type":"source_code_comment","comment":"       I - INFECTED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491902"}},
                    {"metadata_type":"source_code_comment","comment":"       D - DIAGNOSED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":9,"block":2,"char_begin":765,"char_end":812},"variable_identifier":"start of active intervention","value":{"value":"30"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_active_cases","description":"number of active cases","score":0.7907208},{"argument_name":"variable","id":"apollosv:00000208","description":"control strategy start time information","score":0.7838213},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7733535},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7656297},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7652983}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":13,"col_end":14,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491915"}},
                    {"metadata_type":"source_code_comment","comment":"    y (tuple of float): A tuple representing the current values of the state variables:","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"       A - AILING","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":199,"char_end":215},"variable_identifier":"C","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":5,"block":5,"char_begin":470,"char_end":490},"variable_identifier":"C","unit_type":"omegal - omegaj","grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":1065,"char_end":1072},"variable_identifier":"C","value":{"value":"0.5"},"grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":1065,"char_end":1072},"variable_identifier":"C","variable_definition":"reinfection parameter","grounding":[{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7195074},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.6745472},{"argument_name":"description","id":"apollosv:00000404","description":"infectiousness","score":0.6619116},{"argument_name":"description","id":"cemo:herd_immunity_threshold","description":"herd immunity threshold","score":0.6509086},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.6497471},{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":16,"col_end":17,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491931"}},
                    {"metadata_type":"source_code_comment","comment":"       R - RECOGNISED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":21,"block":2,"char_begin":198,"char_end":246},"variable_identifier":"number of infected population","value":{"value":"two"},"grounding":[{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.6192232},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.6132377},{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6119258},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.5981576},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.5760142}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":20,"block":4,"char_begin":153,"char_end":188},"variable_identifier":"are of ten source of instability","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"apollosv:00000113","description":"atmosphere of the Earth","score":0.787738},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7835881},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7649537},{"argument_name":"variable","id":"apollosv:00000446","description":"ratio of outdoor to indoor ovisites","score":0.7613834},{"argument_name":"variable","id":"apollosv:00000491","description":"identifier of species of population","score":0.7598093}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":19,"col_end":20,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491945"}},
                    {"metadata_type":"source_code_comment","comment":"       T - THREATENED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":22,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491958"}},
                    {"metadata_type":"source_code_comment","comment":"       H - HEALED","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":339,"char_end":356},"variable_identifier":"SIHRD model n","value":{"value":"5"},"grounding":[{"argument_name":"variable","id":"apollosv:00000551","description":"Susceptible-Exposed-Infectious-Recovered model","score":0.7602279},{"argument_name":"variable","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.7125074},{"argument_name":"variable","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.6826137},{"argument_name":"variable","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.6722575},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.6373796}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":37,"line_end":37,"col_begin":25,"col_end":26,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491972"}},
                    {"metadata_type":"source_code_comment","comment":"       E - EXTINCT","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":11,"col_end":13,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492016"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":15,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492062"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":15,"col_end":25,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492135"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":28,"col_end":35,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492190"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":28,"col_end":37,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492251"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":15,"col_end":37,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492301"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":40,"col_end":48,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492338"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":40,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492404"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":15,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492456"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":53,"col_end":61,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492493"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":53,"col_end":63,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492587"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":15,"col_end":63,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492639"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":11,"col_end":64,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492673"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":40,"line_end":40,"col_begin":4,"col_end":64,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.491992"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":14,"col_end":22,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492823"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":14,"col_end":24,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492876"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":27,"col_end":34,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492927"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":27,"col_end":36,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492983"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":14,"col_end":36,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493031"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":39,"col_end":47,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493068"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":39,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493124"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":14,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493172"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":52,"col_end":60,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493209"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":52,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493265"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":14,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493317"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":11,"col_end":63,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493348"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":67,"col_end":77,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493401"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":80,"col_end":87,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493471"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":67,"col_end":87,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493537"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":90,"col_end":97,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493589"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":67,"col_end":97,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493654"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":66,"col_end":100,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493695"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":11,"col_end":100,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493731"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":43,"line_end":43,"col_begin":4,"col_end":100,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.492784"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":11,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493887"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":11,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493943"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":27,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493998"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":36,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494063"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":27,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494122"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":26,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494169"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":11,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494205"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":46,"line_end":46,"col_begin":4,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.493863"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":11,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494315"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":11,"col_end":20,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494393"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":24,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494451"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":35,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494520"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":24,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494585"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":43,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494634"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":24,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494699"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":23,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494735"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":11,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494770"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":49,"line_end":49,"col_begin":4,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494291"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":11,"col_end":17,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494890"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":11,"col_end":19,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494948"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":22,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495003"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":22,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495063"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":11,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495112"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":36,"col_end":41,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495152"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":44,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495222"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":36,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495336"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":35,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495385"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":11,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495421"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":52,"line_end":52,"col_begin":4,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.494857"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":11,"col_end":16,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495558"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":11,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495617"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":21,"col_end":26,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495669"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":21,"col_end":28,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495734"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":11,"col_end":28,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495784"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":32,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495866"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":43,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495985"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":32,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496056"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":31,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496105"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":11,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496181"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":55,"line_end":55,"col_begin":4,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.495530"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496370"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":20,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496450"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":23,"col_end":29,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496506"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":23,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496570"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496617"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":34,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496653"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":34,"col_end":44,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496718"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":44,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496768"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":47,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496804"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":47,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496869"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496923"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":57,"col_end":65,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496964"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":57,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497031"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":11,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497085"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":58,"line_end":58,"col_begin":4,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.496336"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":61,"line_end":61,"col_begin":11,"col_end":17,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497276"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":61,"line_end":61,"col_begin":11,"col_end":19,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497339"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":61,"line_end":61,"col_begin":4,"col_end":19,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497242"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":64,"line_end":64,"col_begin":4,"col_end":57,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497435"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":64,"line_end":64,"col_begin":11,"col_end":57,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497508"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":87,"col_begin":0,"col_end":14,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497803"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":17,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497827"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":20,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497848"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":339,"char_end":356},"variable_identifier":"SIHRD model n","value":{"value":"5"},"grounding":[{"argument_name":"variable","id":"apollosv:00000551","description":"Susceptible-Exposed-Infectious-Recovered model","score":0.7602279},{"argument_name":"variable","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.7125074},{"argument_name":"variable","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.6826137},{"argument_name":"variable","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.6722575},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.6373796}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":23,"col_end":24,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497869"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":26,"col_end":27,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497889"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":9,"block":2,"char_begin":765,"char_end":812},"variable_identifier":"start of active intervention","value":{"value":"30"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_active_cases","description":"number of active cases","score":0.7907208},{"argument_name":"variable","id":"apollosv:00000208","description":"control strategy start time information","score":0.7838213},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7733535},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7656297},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7652983}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":29,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497909"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":199,"char_end":215},"variable_identifier":"C","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":5,"block":5,"char_begin":470,"char_end":490},"variable_identifier":"C","unit_type":"omegal - omegaj","grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":1065,"char_end":1072},"variable_identifier":"C","value":{"value":"0.5"},"grounding":[{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":1065,"char_end":1072},"variable_identifier":"C","variable_definition":"reinfection parameter","grounding":[{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7195074},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.6745472},{"argument_name":"description","id":"apollosv:00000404","description":"infectiousness","score":0.6619116},{"argument_name":"description","id":"cemo:herd_immunity_threshold","description":"herd immunity threshold","score":0.6509086},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.6497471},{"argument_name":"variable","id":"vo:0004004","description":"BoNT/C","score":0.7589515},{"argument_name":"variable","id":"vo:0010725","description":"Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C","score":0.618067},{"argument_name":"variable","id":"vo:0004859","description":"meningococcal group C polysaccharide","score":0.6166357},{"argument_name":"variable","id":"ncit:C19506","description":"Basic and Preclinical-Subcommittee C","score":0.6094921},{"argument_name":"variable","id":"vo:0000051","description":"Balb/c mouse","score":0.6017602}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":32,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497930"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":21,"block":2,"char_begin":198,"char_end":246},"variable_identifier":"number of infected population","value":{"value":"two"},"grounding":[{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.6192232},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.6132377},{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6119258},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.5981576},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.5760142}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":20,"block":4,"char_begin":153,"char_end":188},"variable_identifier":"are of ten source of instability","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"apollosv:00000113","description":"atmosphere of the Earth","score":0.787738},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7835881},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7649537},{"argument_name":"variable","id":"apollosv:00000446","description":"ratio of outdoor to indoor ovisites","score":0.7613834},{"argument_name":"variable","id":"apollosv:00000491","description":"identifier of species of population","score":0.7598093}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":35,"col_end":36,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497950"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":38,"col_end":39,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497973"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":339,"char_end":356},"variable_identifier":"SIHRD model n","value":{"value":"5"},"grounding":[{"argument_name":"variable","id":"apollosv:00000551","description":"Susceptible-Exposed-Infectious-Recovered model","score":0.7602279},{"argument_name":"variable","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.7125074},{"argument_name":"variable","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.6826137},{"argument_name":"variable","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.6722575},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.6373796}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":67,"line_end":67,"col_begin":41,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.497993"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":300,"char_end":326},"variable_identifier":"., for the SIR model n","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7130031},{"argument_name":"variable","id":"ncit:C20171","description":"Component of the Center for Cancer Research","score":0.7014262},{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.6896356},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.6888397},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.6758065}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498091"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":25,"col_end":26,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498067"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498128"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":27,"col_end":28,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498120"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498175"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":38,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498169"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":12,"col_end":44,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498151"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498221"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":41,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498215"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":12,"col_end":44,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498151"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":4,"col_end":5,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498299"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":10,"char_begin":485,"char_end":509},"variable_identifier":"H","variable_definition":"SIR model","grounding":[{"argument_name":"description","id":"apollosv:00000549","description":"Susceptible-Infected-Resistant model","score":0.840641},{"argument_name":"description","id":"apollosv:00000001","description":"epidemic model","score":0.7430583},{"argument_name":"description","id":"apollosv:00000612","description":"network model","score":0.7428662},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.7226676},{"argument_name":"description","id":"apollosv:00000553","description":"two-strain Susceptible-Infectious-Resistant model","score":0.7206744},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":116,"char_end":122},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4018,"char_end":4023},"variable_identifier":"H","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":4,"char_begin":342,"char_end":351},"variable_identifier":"H","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":15,"block":5,"char_begin":342,"char_end":368},"variable_identifier":"H","value":{"value":"35000"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":68,"line_end":68,"col_begin":7,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498314"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498372"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":18,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498366"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498452"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":29,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498411"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":4,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498394"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498611"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":44,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498604"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":4,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498542"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498796"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":53,"col_end":66,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498788"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":69,"line_end":69,"col_begin":4,"col_end":67,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498770"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498909"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":18,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498903"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498957"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":29,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498949"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498932"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499021"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":44,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499015"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.498998"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499082"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":53,"col_end":100,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499075"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":70,"line_end":70,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499058"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499199"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":18,"col_end":22,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499192"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499243"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":30,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499238"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499221"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499303"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":45,"col_end":46,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499297"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499281"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499369"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":54,"col_end":100,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499362"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":71,"line_end":71,"col_begin":4,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499343"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499486"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":18,"col_end":22,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499480"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499531"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":30,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499526"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":4,"col_end":99,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499509"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499594"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":45,"col_end":46,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499589"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":4,"col_end":99,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499572"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499668"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":54,"col_end":98,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499655"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":72,"line_end":72,"col_begin":4,"col_end":99,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499636"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499792"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":18,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499786"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499838"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":31,"col_end":34,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499832"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":4,"col_end":102,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499816"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499901"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":46,"col_end":47,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499896"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":4,"col_end":102,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499877"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499967"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":55,"col_end":101,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499959"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":73,"line_end":73,"col_begin":4,"col_end":102,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.499941"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500118"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":18,"col_end":23,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500112"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500166"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":31,"col_end":34,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500160"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":4,"col_end":90,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500143"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500233"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":46,"col_end":47,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500227"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":4,"col_end":90,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500208"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500297"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":55,"col_end":89,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500289"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":74,"line_end":74,"col_begin":4,"col_end":90,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500272"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500429"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":18,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500423"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500481"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":29,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500475"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":4,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500458"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500545"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":44,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500539"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":4,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500522"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500610"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":53,"col_end":61,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500602"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":75,"line_end":75,"col_begin":4,"col_end":62,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500585"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500751"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":18,"col_end":21,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500744"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500800"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":29,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500794"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":4,"col_end":70,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500777"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500867"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":44,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500859"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":4,"col_end":70,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500842"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500934"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":53,"col_end":69,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500926"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":76,"line_end":76,"col_begin":4,"col_end":70,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.500908"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501078"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":78,"line_end":78,"col_begin":18,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501072"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501155"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":79,"line_end":79,"col_begin":18,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501149"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501235"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":81,"line_end":81,"col_begin":36,"col_end":37,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501230"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":81,"line_end":81,"col_begin":4,"col_end":38,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501213"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501332"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":82,"line_end":82,"col_begin":36,"col_end":37,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501326"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":82,"line_end":82,"col_begin":4,"col_end":38,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501309"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'bool'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501453"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":14,"col_end":18,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501447"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":4,"col_end":55,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501430"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501518"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":26,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501512"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":4,"col_end":55,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501495"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501606"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":37,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501600"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":4,"col_end":55,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501583"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'int'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501679"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":45,"col_end":46,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501670"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":4,"col_end":55,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501651"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'str'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501744"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":51,"col_end":54,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501738"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":83,"line_end":83,"col_begin":4,"col_end":55,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501721"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"<class 'float'>","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501928"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":85,"line_end":85,"col_begin":33,"col_end":36,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.501923"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":95,"line_end":95,"col_begin":0,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502027"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":95,"line_end":95,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502046"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":95,"line_end":95,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502095"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502122"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":95,"line_end":95,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502114"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502151"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":95,"line_end":95,"col_begin":45,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502143"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":96,"line_end":96,"col_begin":0,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502208"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":96,"line_end":96,"col_begin":9,"col_end":10,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502227"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":96,"line_end":96,"col_begin":20,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502271"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502297"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":96,"line_end":96,"col_begin":36,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502291"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502323"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":96,"line_end":96,"col_begin":44,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502317"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":97,"line_end":97,"col_begin":0,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502381"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":97,"line_end":97,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502399"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":97,"line_end":97,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502440"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502467"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":97,"line_end":97,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502458"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502496"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":97,"line_end":97,"col_begin":45,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502487"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":98,"line_end":98,"col_begin":0,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502552"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":98,"line_end":98,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502571"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":98,"line_end":98,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502611"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502635"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":98,"line_end":98,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502629"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502661"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":98,"line_end":98,"col_begin":45,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502655"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":100,"line_end":100,"col_begin":0,"col_end":53,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502719"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":3,"char_begin":364,"char_end":389},"variable_identifier":"S","variable_definition":"susceptible population","grounding":[{"argument_name":"description","id":"apollosv:00000234","description":"susceptible population","score":0.9988711},{"argument_name":"description","id":"apollosv:00000154","description":"exposed population","score":0.85467},{"argument_name":"description","id":"cemo:susceptible_individuals","description":"susceptible individuals","score":0.8514675},{"argument_name":"description","id":"ncit:C71551","description":"Exposed Population","score":0.8392252},{"argument_name":"description","id":"apollosv:00000233","description":"infected population","score":0.831711},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4032,"char_end":4037},"variable_identifier":"S","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":11,"char_begin":2040,"char_end":2079},"variable_identifier":"S","variable_definition":"limit","grounding":[{"argument_name":"description","id":"ncit:C178630","description":"Limit or Avoid Public Places","score":0.6700745},{"argument_name":"description","id":"ncit:C178629","description":"Limit or Avoid Gatherings Greater than 10 People","score":0.60331},{"argument_name":"description","id":"ncit:C178631","description":"Limit Gatherings to Cohabitants","score":0.5927269},{"argument_name":"description","id":"apollosv:00000131","description":"reactive control strategy threshold","score":0.5628151},{"argument_name":"description","id":"apollosv:00000295","description":"reactive control strategy threshold unit of measure","score":0.5619082},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":3,"block":7,"char_begin":94,"char_end":184},"variable_identifier":"S","variable_definition":"disjoint compartments","grounding":[{"argument_name":"description","id":"apollosv:00000250","description":"discrete parametric probability distribution","score":0.5653679},{"argument_name":"description","id":"apollosv:00000216","description":"discrete probability distribution","score":0.5639799},{"argument_name":"description","id":"apollosv:00000252","description":"discrete nonparametric probability distribution","score":0.5373608},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7847759},{"argument_name":"variable","id":"vo:0000866","description":"Fluviral S/F","score":0.7649184},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6509971},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6471661},{"argument_name":"variable","id":"ncit:A31","description":"Has_GDC_Value","score":0.5984588}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":100,"line_end":100,"col_begin":12,"col_end":13,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502737"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":100,"line_end":100,"col_begin":23,"col_end":35,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502780"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502808"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":100,"line_end":100,"col_begin":39,"col_end":45,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502801"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502836"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":100,"line_end":100,"col_begin":47,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502828"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":101,"line_end":101,"col_begin":0,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502899"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":101,"line_end":101,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502918"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":101,"line_end":101,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502958"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502982"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":101,"line_end":101,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.502976"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503009"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":101,"line_end":101,"col_begin":45,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503002"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":103,"line_end":103,"col_begin":0,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503068"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":103,"line_end":103,"col_begin":9,"col_end":10,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503087"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":103,"line_end":103,"col_begin":20,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503127"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503153"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":103,"line_end":103,"col_begin":36,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503147"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503178"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":103,"line_end":103,"col_begin":44,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503173"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":104,"line_end":104,"col_begin":0,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503239"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":104,"line_end":104,"col_begin":8,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503260"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":104,"line_end":104,"col_begin":19,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503302"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503352"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":104,"line_end":104,"col_begin":35,"col_end":41,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503346"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503379"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":104,"line_end":104,"col_begin":43,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503373"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":106,"line_end":106,"col_begin":0,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503445"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":106,"line_end":106,"col_begin":7,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503464"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":106,"line_end":106,"col_begin":18,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503504"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503531"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":106,"line_end":106,"col_begin":34,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503525"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503559"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":106,"line_end":106,"col_begin":42,"col_end":48,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503552"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":107,"line_end":107,"col_begin":0,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503625"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":107,"line_end":107,"col_begin":7,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503646"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":107,"line_end":107,"col_begin":18,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503686"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503710"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":107,"line_end":107,"col_begin":34,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503704"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503736"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":107,"line_end":107,"col_begin":42,"col_end":48,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503730"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":108,"line_end":108,"col_begin":0,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503795"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":108,"line_end":108,"col_begin":9,"col_end":10,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503841"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":108,"line_end":108,"col_begin":20,"col_end":32,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503900"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503928"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":108,"line_end":108,"col_begin":36,"col_end":42,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503922"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503953"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":108,"line_end":108,"col_begin":44,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.503947"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":109,"line_end":109,"col_begin":0,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504015"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":109,"line_end":109,"col_begin":8,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504036"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":109,"line_end":109,"col_begin":19,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504076"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504101"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":109,"line_end":109,"col_begin":35,"col_end":41,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504095"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504128"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":109,"line_end":109,"col_begin":43,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504120"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":111,"line_end":111,"col_begin":0,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504279"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":111,"line_end":111,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504331"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":111,"line_end":111,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504374"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504399"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":111,"line_end":111,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504393"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504424"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":111,"line_end":111,"col_begin":45,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504418"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":112,"line_end":112,"col_begin":0,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504490"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":112,"line_end":112,"col_begin":7,"col_end":8,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504509"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":112,"line_end":112,"col_begin":18,"col_end":30,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504553"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504578"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":112,"line_end":112,"col_begin":34,"col_end":40,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504572"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504603"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":112,"line_end":112,"col_begin":42,"col_end":48,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504598"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":113,"line_end":113,"col_begin":0,"col_end":52,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504670"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":113,"line_end":113,"col_begin":10,"col_end":11,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504689"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":113,"line_end":113,"col_begin":21,"col_end":33,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504731"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504755"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":113,"line_end":113,"col_begin":37,"col_end":43,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504749"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504783"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":113,"line_end":113,"col_begin":45,"col_end":51,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504775"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":115,"line_end":115,"col_begin":0,"col_end":50,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504850"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":115,"line_end":115,"col_begin":8,"col_end":9,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504869"}}
                ],
                [
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":115,"line_end":115,"col_begin":19,"col_end":31,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504911"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504935"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":115,"line_end":115,"col_begin":35,"col_end":41,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504929"}}
                ],
                [
                    {"metadata_type":"source_code_data_type","source_language":"Python","source_language_version":"3.8","data_type":"List","provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504960"}},
                    {"metadata_type":"source_code_reference","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","line_begin":115,"line_end":115,"col_begin":43,"col_end":49,"provenance":{"method":"skema_code2fn_program_analysis","timestamp":"2023-01-30 11:12:21.504954"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":462,"char_end":495},"variable_identifier":"h","variable_definition":"function","grounding":[{"argument_name":"description","id":"vo:0000278","description":"vaccine function","score":0.7583471},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7230266},{"argument_name":"description","id":"apollosv:00000556","description":"mechanical flight function","score":0.7120805},{"argument_name":"description","id":"vo:0000562","description":"therapeutic vaccine function","score":0.6768057},{"argument_name":"description","id":"vo:0000452","description":"preventive vaccine function","score":0.6282237},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":415,"char_end":427},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":10,"char_begin":609,"char_end":621},"variable_identifier":"h","variable_definition":"constraint","grounding":[{"argument_name":"description","id":"apollosv:00000068","description":"simulation time step action specification","score":0.6318445},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.6178974},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.6165611},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.5968132},{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.5901485},{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":24,"block":3,"char_begin":721,"char_end":726},"variable_identifier":"h","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":4,"char_begin":313,"char_end":322},"variable_identifier":"h","value":{"value":"0.114"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"621eee202688b71135317157.pdf","page":13,"block":12,"char_begin":64,"char_end":183},"variable_identifier":"h","value":{"value":"13"},"grounding":[{"argument_name":"variable","id":"ncit:C19511","description":"Clinical Groups-Subcommittee H","score":0.7447917},{"argument_name":"variable","id":"vo:0005133","description":"MVvac2-MERS-S(H) vaccine","score":0.7120038},{"argument_name":"variable","id":"vo:0004141","description":"Zoosaloral H.","score":0.677867},{"argument_name":"variable","id":"vo:0011166","description":"H hemagglutinin protein","score":0.6590042},{"argument_name":"variable","id":"vo:0011052","description":"CDVgp6 haemagglutinin protein H","score":0.6491526}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":12,"block":2,"char_begin":419,"char_end":431},"variable_identifier":"x","unit_type":"S, I, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":14,"block":3,"char_begin":214,"char_end":226},"variable_identifier":"x","unit_type":"S, i, R","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8620201},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8050106},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7206978},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6746103},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.617825},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":16,"block":1,"char_begin":54,"char_end":72},"variable_identifier":"x","unit_type":"S, I, H, R, D","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8450551},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.8024819},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.7096648},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6636155},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6582307},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":8,"block":1,"char_begin":1234,"char_end":1248},"variable_identifier":"x","unit_type":"I D A R T","grounding":[{"argument_name":"unit","id":"vo:0003109","description":"Meruvax I","score":0.8618963},{"argument_name":"unit","id":"vo:0000866","description":"Fluviral S/F","score":0.7124579},{"argument_name":"unit","id":"vo:0003118","description":"M-M-R I","score":0.6869799},{"argument_name":"unit","id":"vo:0010898","description":"E0","score":0.6769257},{"argument_name":"unit","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.6598789},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ee22d2e725b01fb00406d54.pdf","page":25,"block":4,"char_begin":525,"char_end":574},"variable_identifier":"x","variable_definition":"case","grounding":[{"argument_name":"description","id":"apollosv:00000558","description":"case series","score":0.8418106},{"argument_name":"description","id":"covoc:0010003","description":"confirmed case","score":0.8346326},{"argument_name":"description","id":"apollosv:00000398","description":"infection case record","score":0.8239901},{"argument_name":"description","id":"apollosv:00000296","description":"case definition","score":0.8184391},{"argument_name":"description","id":"cemo:initial_infection_case","description":"initial infection case","score":0.795766},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","value":{"value":"1,               0"},"grounding":[{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":1172,"char_end":1194},"variable_identifier":"x","variable_definition":"thesensitivityindexof   0 withregardsto","grounding":[{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.8210179},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.6984895},{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.6518611},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.6421377},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.6342463},{"argument_name":"value","id":"vo:0004706","description":"SG33-VP2/5","score":0.8332621},{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.7378072},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.7292741},{"argument_name":"value","id":"vo:0003109","description":"Meruvax I","score":0.7218106},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.678533},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60a7e9813f2ac7e701375253.pdf","page":11,"block":0,"char_begin":904,"char_end":922},"variable_identifier":"x","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":222,"char_end":234},"variable_identifier":"x","variable_definition":"(1 gammaa x","grounding":[{"argument_name":"description","id":"vo:0002721","description":"gH from Herpes simplex virus type 1 and 2","score":0.6817848},{"argument_name":"description","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6810402},{"argument_name":"description","id":"vo:0002723","description":"TK from Herpes simplex virus type 1 and 2","score":0.6723241},{"argument_name":"description","id":"vo:0010834","description":"Herpes simplex virus type 1 and 2 protein","score":0.6638938},{"argument_name":"description","id":"vo:0002720","description":"gD from Herpes simplex virus type 1 and 2","score":0.6618558},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f2d7604a58f1dfd5210abe5.pdf","page":6,"block":1,"char_begin":326,"char_end":334},"variable_identifier":"x","variable_definition":"4 - gammaa x 2 - mux 2 =","grounding":[{"argument_name":"description","id":"vo:0011326","description":"CEL-170/4","score":0.8344415},{"argument_name":"description","id":"vo:0003109","description":"Meruvax I","score":0.7628474},{"argument_name":"description","id":"ncit:C132426","description":"Rater 2","score":0.7561454},{"argument_name":"description","id":"ncit:C132425","description":"Rater 1","score":0.7255096},{"argument_name":"description","id":"vo:0004706","description":"SG33-VP2/5","score":0.7093373},{"argument_name":"variable","id":"vo:0002719","description":"HBVgp3 X protein from Hepatitis B virus","score":0.6531852},{"argument_name":"variable","id":"vo:0002969","description":"Hepatitis B virus X protein mutant vaccine","score":0.5717895},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.5092828},{"argument_name":"variable","id":"vo:0003259","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.02 MG/ML Injection","score":0.5068268},{"argument_name":"variable","id":"vo:0003426","description":"1 ML Hepatitis B Surface Antigen Vaccine 0.01 MG/ML Injection","score":0.5038241}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":5,"char_begin":655,"char_end":686},"variable_identifier":"., some form of mitigation","value":{"value":".,"},"grounding":[{"argument_name":"variable","id":"ncit:P317","description":"FDA_Table","score":0.7161716},{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7052321},{"argument_name":"variable","id":"ncit:A11","description":"Has_NICHD_Parent","score":0.7050903},{"argument_name":"variable","id":"apollosv:00000337","description":"ectosymbiosis","score":0.6982666},{"argument_name":"variable","id":"ncit:P106","description":"Semantic_Type","score":0.6934654}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"61a3d8d567467f7269520df0.pdf","page":4,"block":5,"char_begin":1702,"char_end":1744},"variable_identifier":"increase in R 0 to 1.12 at the end of May","value":{"value":"1.12"},"grounding":[{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7706879},{"argument_name":"variable","id":"apollosv:00000281","description":"number of doses in a treatment course","score":0.7698181},{"argument_name":"variable","id":"apollosv:00000345","description":"ectosymbiotic parasitoidism","score":0.7692459},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7686486},{"argument_name":"variable","id":"vo:0003116","description":"TD-Rix","score":0.7662914}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":25,"block":3,"char_begin":602,"char_end":639},"variable_identifier":"context of hospitalizations","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7523741},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7503833},{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7479954},{"argument_name":"variable","id":"cemo:proportion_of_cases_attributed_to_travel","description":"proportion of cases attributed to travel","score":0.7285686},{"argument_name":"variable","id":"cemo:prevalence_of_comorbidities_cases","description":"prevalence of comorbidities cases","score":0.7205157}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f525fefa58f1dfd521414f8.pdf","page":10,"block":7,"char_begin":422,"char_end":476},"variable_identifier":"chi3","variable_definition":"chi1 chi2","grounding":[{"argument_name":"description","id":"ncit:C44586","description":"Eek","score":0.5778612},{"argument_name":"description","id":"ncit:C44517","description":"Yana","score":0.5518758},{"argument_name":"description","id":"vo:0011206","description":"Gnd","score":0.5441932},{"argument_name":"description","id":"vo:0011160","description":"BT1","score":0.54176},{"argument_name":"description","id":"ncit:C43996","description":"Kaw","score":0.5321796},{"argument_name":"variable","id":"ncit:C44574","description":"Aniak","score":0.6718518},{"argument_name":"variable","id":"ncit:C44586","description":"Eek","score":0.6567167},{"argument_name":"variable","id":"vo:0011160","description":"BT1","score":0.6532708},{"argument_name":"variable","id":"ncit:C44679","description":"Golovin","score":0.6529739},{"argument_name":"variable","id":"ncit:C67271","description":"Bahamian","score":0.638325}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":25,"block":2,"char_begin":683,"char_end":731},"variable_identifier":"colors of states on the map","value":{"value":"7"},"grounding":[{"argument_name":"variable","id":"apollosv:00000113","description":"atmosphere of the Earth","score":0.7706656},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.76036},{"argument_name":"variable","id":"apollosv:00000376","description":"name of a temporal boundary","score":0.7552638},{"argument_name":"variable","id":"apollosv:00000491","description":"identifier of species of population","score":0.7464637},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7421719}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5f525fefa58f1dfd521414f8.pdf","page":10,"block":13,"char_begin":3974,"char_end":3990},"variable_identifier":"LAS","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C44541","description":"Las Vegas","score":0.7546118},{"argument_name":"variable","id":"ncit:C95528","description":"Forma","score":0.6991593},{"argument_name":"variable","id":"ncit:C180341","description":"Grupo Espanol de Investigacion en Sarcomas","score":0.5975675},{"argument_name":"variable","id":"ncit:C43968","description":"Agua Caliente","score":0.5934479},{"argument_name":"variable","id":"ncit:C43905","description":"Agua Caliente Cahuilla","score":0.5902803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"61a3d8d567467f7269520df0.pdf","page":3,"block":5,"char_begin":84,"char_end":129},"variable_identifier":"three datasets of active, recovered and death","value":{"value":"three"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6562709},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.6078457},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.5837353},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.5695707},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.5690374},{"argument_name":"variable","id":"cemo:number_of_active_cases","description":"number of active cases","score":0.8225745},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7794985},{"argument_name":"variable","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.7631327},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.7610777},{"argument_name":"variable","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7610382}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"61a3d8d567467f7269520df0.pdf","page":4,"block":5,"char_begin":1702,"char_end":1744},"variable_identifier":"increase in R 0 to 1.12 at the end of May","value":{"value":"1.12"},"grounding":[{"argument_name":"variable","id":"apollosv:00000279","description":"probability of exit from a country is denied","score":0.7706879},{"argument_name":"variable","id":"apollosv:00000281","description":"number of doses in a treatment course","score":0.7698181},{"argument_name":"variable","id":"apollosv:00000345","description":"ectosymbiotic parasitoidism","score":0.7692459},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7686486},{"argument_name":"variable","id":"vo:0003116","description":"TD-Rix","score":0.7662914}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":25,"block":3,"char_begin":602,"char_end":639},"variable_identifier":"context of hospitalizations","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7523741},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7503833},{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7479954},{"argument_name":"variable","id":"cemo:proportion_of_cases_attributed_to_travel","description":"proportion of cases attributed to travel","score":0.7285686},{"argument_name":"variable","id":"cemo:prevalence_of_comorbidities_cases","description":"prevalence of comorbidities cases","score":0.7205157}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f525fefa58f1dfd521414f8.pdf","page":10,"block":7,"char_begin":422,"char_end":476},"variable_identifier":"chi3","variable_definition":"chi1 chi2","grounding":[{"argument_name":"description","id":"ncit:C44586","description":"Eek","score":0.5778612},{"argument_name":"description","id":"ncit:C44517","description":"Yana","score":0.5518758},{"argument_name":"description","id":"vo:0011206","description":"Gnd","score":0.5441932},{"argument_name":"description","id":"vo:0011160","description":"BT1","score":0.54176},{"argument_name":"description","id":"ncit:C43996","description":"Kaw","score":0.5321796},{"argument_name":"variable","id":"ncit:C44574","description":"Aniak","score":0.6718518},{"argument_name":"variable","id":"ncit:C44586","description":"Eek","score":0.6567167},{"argument_name":"variable","id":"vo:0011160","description":"BT1","score":0.6532708},{"argument_name":"variable","id":"ncit:C44679","description":"Golovin","score":0.6529739},{"argument_name":"variable","id":"ncit:C67271","description":"Bahamian","score":0.638325}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":1,"block":4,"char_begin":320,"char_end":355},"variable_identifier":"inherent","value":{"value":"ten"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.5860152},{"argument_name":"value","id":"ncit:C44021","description":"Twenty-Nine Palms","score":0.5177912},{"argument_name":"variable","id":"ncit:C154707","description":"Technical Lead","score":0.5401045},{"argument_name":"variable","id":"apollosv:00000000","description":"purely intentional entity","score":0.5262416},{"argument_name":"variable","id":"vo:0011260","description":"LACK","score":0.5203256},{"argument_name":"variable","id":"ncit:C53670","description":"Fundamental Nanoscale Phenomena and Processes","score":0.50629},{"argument_name":"variable","id":"apollosv:00000402","description":"individual human behavior","score":0.5038454}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":25,"block":2,"char_begin":683,"char_end":731},"variable_identifier":"colors of states on the map","value":{"value":"7"},"grounding":[{"argument_name":"variable","id":"apollosv:00000113","description":"atmosphere of the Earth","score":0.7706656},{"argument_name":"variable","id":"ncit:C20169","description":"Component of the Office of the Director","score":0.76036},{"argument_name":"variable","id":"apollosv:00000376","description":"name of a temporal boundary","score":0.7552638},{"argument_name":"variable","id":"apollosv:00000491","description":"identifier of species of population","score":0.7464637},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7421719}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5f525fefa58f1dfd521414f8.pdf","page":10,"block":13,"char_begin":3974,"char_end":3990},"variable_identifier":"LAS","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"ncit:C44541","description":"Las Vegas","score":0.7546118},{"argument_name":"variable","id":"ncit:C95528","description":"Forma","score":0.6991593},{"argument_name":"variable","id":"ncit:C180341","description":"Grupo Espanol de Investigacion en Sarcomas","score":0.5975675},{"argument_name":"variable","id":"ncit:C43968","description":"Agua Caliente","score":0.5934479},{"argument_name":"variable","id":"ncit:C43905","description":"Agua Caliente Cahuilla","score":0.5902803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"61a3d8d567467f7269520df0.pdf","page":3,"block":5,"char_begin":84,"char_end":129},"variable_identifier":"three datasets of active, recovered and death","value":{"value":"three"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6562709},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.6078457},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.5837353},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.5695707},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.5690374},{"argument_name":"variable","id":"cemo:number_of_active_cases","description":"number of active cases","score":0.8225745},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7794985},{"argument_name":"variable","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.7631327},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.7610777},{"argument_name":"variable","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7610382}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":10,"char_begin":678,"char_end":706},"variable_identifier":"period of less","unit_type":"months","grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7975636},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7671891},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7606019},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7538922},{"argument_name":"variable","id":"apollosv:00000438","description":"fraction reduction of eggs","score":0.752983},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4088,"char_end":4135},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3551,"char_end":3592},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3672,"char_end":3712},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":1,"block":8,"char_begin":530,"char_end":568},"variable_identifier":"period of training","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7635042},{"argument_name":"variable","id":"ncit:C19205","description":"Office of Centers, Training, and Resources","score":0.7578517},{"argument_name":"variable","id":"apollosv:00000066","description":"simulation of time step","score":0.7567638},{"argument_name":"variable","id":"apollosv:00000280","description":"duration of treatment course","score":0.7432972},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7311535}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2054,"char_end":2085},"variable_identifier":"death curve","value":{"value":"0.1"},"grounding":[{"argument_name":"variable","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.7785762},{"argument_name":"variable","id":"ncit:C107103","description":"Sudden Death","score":0.7305934},{"argument_name":"variable","id":"cemo:new_daily_death_rates","description":"new daily death rates","score":0.7020919},{"argument_name":"variable","id":"cemo:case_fatality_rate","description":"case fatality rate","score":0.6827369},{"argument_name":"variable","id":"ncit:C173779","description":"Case Fatality Rate","score":0.6825308}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":0,"char_end":104},"variable_identifier":"Table 1 Evaluation of different models on 5 representative countries, for predicting COVID-19 infections","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.7686741},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7654569},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.7526997},{"argument_name":"variable","id":"ncit:C142390","description":"Analysis Set of Subjects","score":0.7516723},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7471803}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":531,"char_end":645},"variable_identifier":"addition of dynamics governing the evolution of populations associated with hospitalization and deaths","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.816651},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.8050162},{"argument_name":"variable","id":"ncit:C20170","description":"Component of the Division of Cancer Control and Population Sciences","score":0.8004918},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7966845},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.7966216}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":246,"char_end":288},"variable_identifier":"significance","value":{"value":"0.1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":387,"char_end":433},"variable_identifier":"D","variable_definition":"respectively20","grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":18,"block":1,"char_begin":142,"char_end":148},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":3974,"char_end":3983},"variable_identifier":"D","value":{"value":"20/60"},"grounding":[{"argument_name":"value","id":"ncit:C43895","description":"Assiniboine","score":0.6497798},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6117202},{"argument_name":"value","id":"ncit:C43939","description":"Choctaw","score":0.6108686},{"argument_name":"value","id":"ncit:C44586","description":"Eek","score":0.6087494},{"argument_name":"value","id":"ncit:C44228","description":"Winnemucca","score":0.6005827},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":11,"block":9,"char_begin":590,"char_end":595},"variable_identifier":"D","value":{"value":"9"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":5,"char_begin":33,"char_end":38},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":4,"char_begin":86,"char_end":91},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":13,"block":4,"char_begin":301,"char_end":306},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":15,"block":9,"char_begin":167,"char_end":172},"variable_identifier":"D","value":{"value":"0"},"grounding":[{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.7496396},{"argument_name":"variable","id":"ncit:C19507","description":"Clinical Studies-Subcommittee D","score":0.6734273},{"argument_name":"variable","id":"vo:0004706","description":"SG33-VP2/5","score":0.6504841},{"argument_name":"variable","id":"vo:0003118","description":"M-M-R I","score":0.6386476},{"argument_name":"variable","id":"vo:0001091","description":"Poulvac FluFend I AI H5N3 RG","score":0.634005}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":430,"char_end":468},"variable_identifier":"sufficient data (for at least 3 months","unit_type":"months","grounding":[{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7999391},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7970024},{"argument_name":"variable","id":"vo:0003119","description":"Hib-Imune","score":0.7915544},{"argument_name":"variable","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.7892118},{"argument_name":"variable","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.7879498},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7775041},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.6832901},{"argument_name":"unit","id":"vo:0004940","description":"human age 6 months at vaccination","score":0.6580298},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6429661},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6339377}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":261,"char_end":276},"variable_identifier":"Imax","value":{"value":"200, 000"},"grounding":[{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.6326628},{"argument_name":"value","id":"vo:0010908","description":"RplL","score":0.5806789},{"argument_name":"value","id":"ncit:C43943","description":"Mowa Band of Choctaw","score":0.5705284},{"argument_name":"value","id":"vo:0005195","description":"V590","score":0.567756},{"argument_name":"value","id":"vo:0010985","description":"IreA","score":0.56584},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.6997145},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.5875387},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.5811113},{"argument_name":"variable","id":"vo:0011326","description":"CEL-170/4","score":0.5396937},{"argument_name":"variable","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.5256631}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":1,"char_begin":173,"char_end":222},"variable_identifier":"lowest value of MSE/MAPE","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7719455},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7702795},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7520714},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7486849},{"argument_name":"variable","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.6960993}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":2615,"char_end":2645},"variable_identifier":"young age group","unit_type":"years","grounding":[{"argument_name":"variable","id":"ncit:C20587","description":"Age Group","score":0.9206771},{"argument_name":"variable","id":"ncit:C71550","description":"Age Cohort","score":0.802206},{"argument_name":"variable","id":"vo:0004924","description":"adult age","score":0.7970725},{"argument_name":"variable","id":"ncit:C91107","description":"Young Adult","score":0.7792249},{"argument_name":"variable","id":"vo:0004925","description":"senior age","score":0.7736172},{"argument_name":"unit","id":"ncit:C49683","description":"Children 2-11 Years Old","score":0.7794839},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.7683808},{"argument_name":"unit","id":"ncit:C49685","description":"Adult 18-65 Years Old","score":0.7545403},{"argument_name":"unit","id":"apollosv:00000504","description":"age in years datum","score":0.7140265},{"argument_name":"unit","id":"vo:0000554","description":"human vaccinee at age 2-17 years old","score":0.6968471}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":776,"char_end":790},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1128,"char_end":1136},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":341,"char_end":354},"variable_identifier":"tau","unit_type":"days","grounding":[{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":2,"char_begin":330,"char_end":349},"variable_identifier":"tau","variable_definition":"time delay tau","grounding":[{"argument_name":"description","id":"apollosv:00000272","description":"time since time scale zero","score":0.7538007},{"argument_name":"description","id":"apollosv:00000267","description":"time delay to case detection","score":0.7213483},{"argument_name":"description","id":"apollosv:00000291","description":"time delay of treatment detection","score":0.6992298},{"argument_name":"description","id":"cemo:epidemic_doubling_time","description":"epidemic doubling time","score":0.6988744},{"argument_name":"description","id":"apollosv:00000208","description":"control strategy start time information","score":0.6772895},{"argument_name":"unit","id":"vo:0001203","description":"vaccination-challenge interval in days","score":0.7035089},{"argument_name":"unit","id":"vo:0001197","description":"animal age at vaccination in days","score":0.6849648},{"argument_name":"unit","id":"apollosv:00000575","description":"epidemic start week","score":0.6491049},{"argument_name":"unit","id":"vo:0001100","description":"persons aged 6 months--24 years","score":0.6427485},{"argument_name":"unit","id":"vo:0004934","description":"human age 4 months at vaccination","score":0.6365852},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","value":{"value":"0.01"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4221,"char_end":4231},"variable_identifier":"tau","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":649,"char_end":676},"variable_identifier":"tau","variable_definition":"mortality coefficient","grounding":[{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8224258},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.7202396},{"argument_name":"description","id":"apollosv:00000542","description":"mortality data","score":0.7199964},{"argument_name":"description","id":"cemo:cumulative_excess_mortality","description":"cumulative excess mortality","score":0.710694},{"argument_name":"description","id":"cemo:cumulative_death_rates","description":"cumulative death rates","score":0.704262},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","value":{"value":"0.0100"},"grounding":[{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":677,"char_end":689},"variable_identifier":"tau","variable_definition":"tau","grounding":[{"argument_name":"description","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124},{"argument_name":"variable","id":"vo:0004646","description":"cAdVaxM(fus)","score":0.6847124}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":2,"block":1,"char_begin":1662,"char_end":1771},"variable_identifier":"development of models based on multiple linear regression, Gaussian and Bayesian statistics","value":{"value":"six"},"grounding":[{"argument_name":"value","id":"ncit:C80485","description":"Health Level Seven","score":0.6601487},{"argument_name":"value","id":"apollosv:00000559","description":"case series data set","score":0.5509026},{"argument_name":"value","id":"apollosv:00000558","description":"case series","score":0.529292},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.5148706},{"argument_name":"value","id":"cemo:number_of_tested_specimens","description":"number of tested specimens","score":0.5106519},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7926568},{"argument_name":"variable","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.7380438},{"argument_name":"variable","id":"apollosv:00000183","description":"simulator time specification","score":0.7364984},{"argument_name":"variable","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.7330518},{"argument_name":"variable","id":"apollosv:00000005","description":"simulating of process of type X","score":0.73206}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":2,"block":2,"char_begin":568,"char_end":645},"variable_identifier":"overfitting the largely increased number of parameters","value":{"value":"one"},"grounding":[{"argument_name":"value","id":"vo:0004944","description":"human age within one month at vaccination","score":0.7259995},{"argument_name":"value","id":"cemo:number_of_cases_exposed_by_local_one_or_cluster_case","description":"number of cases exposed by local (one or cluster) case","score":0.7023979},{"argument_name":"value","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.687657},{"argument_name":"value","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.6353125},{"argument_name":"value","id":"apollosv:00000397","description":"infection case list","score":0.6321057},{"argument_name":"variable","id":"cemo:number_of_cases_with_missing_exposure_information","description":"number of cases with missing exposure information","score":0.8172486},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.8089979},{"argument_name":"variable","id":"apollosv:00000059","description":"simulation of organism awaiting effect of control measure","score":0.7988611},{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.790612},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7896045}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":2028,"char_end":2056},"variable_identifier":"lowest value N","value":{"value":"7.5 million"},"grounding":[{"argument_name":"value","id":"ncit:C71557","description":"Standard Million Population","score":0.6711568},{"argument_name":"value","id":"vo:0003967","description":"HEPLISAV-B 20 MCG per 0.5 ML Prefilled Syringe","score":0.5581886},{"argument_name":"value","id":"vo:0003662","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.09 MG/ML","score":0.5548525},{"argument_name":"value","id":"vo:0003717","description":"influenza A virus A/California/7/2009 (H1N1) antigen 0.03 MG/ML / influenza A virus A/South Australia/55/2014 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria 2015-2016]","score":0.5513915},{"argument_name":"value","id":"vo:0003604","description":"influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML","score":0.5511275},{"argument_name":"variable","id":"apollosv:00000433","description":"maximum value","score":0.7941012},{"argument_name":"variable","id":"apollosv:00000432","description":"minimum value","score":0.7689561},{"argument_name":"variable","id":"apollosv:00000462","description":"mean median minimum maximum summary statistics data structure","score":0.6980181},{"argument_name":"variable","id":"cemo:predictive_value_positive","description":"predictive value positive (pvp)","score":0.6959276},{"argument_name":"variable","id":"vo:0004083","description":"V-LSG/N","score":0.67362}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":58,"char_end":67},"variable_identifier":"beta0","variable_definition":"transmission rate","grounding":[{"argument_name":"description","id":"apollosv:00000211","description":"transmission probability","score":0.8650992},{"argument_name":"description","id":"cemo:rate_of_community_transmission","description":"rate of community transmission","score":0.8416166},{"argument_name":"description","id":"apollosv:00000191","description":"transmission coefficient","score":0.8134311},{"argument_name":"description","id":"trans:0000029","description":"cyclopropagative transmission","score":0.8037903},{"argument_name":"description","id":"trans:0000030","description":"cyclodevelopmental transmission","score":0.8016427},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1105,"char_end":1119},"variable_identifier":"beta0","value":{"value":"0.51 1"},"grounding":[{"argument_name":"value","id":"ncit:C132425","description":"Rater 1","score":0.6787661},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6591673},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.6330212},{"argument_name":"value","id":"ncit:C132426","description":"Rater 2","score":0.624294},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6023628},{"argument_name":"variable","id":"vo:0011073","description":"IglC2","score":0.6005743},{"argument_name":"variable","id":"ncit:C43939","description":"Choctaw","score":0.5755858},{"argument_name":"variable","id":"vo:0011206","description":"Gnd","score":0.5703518},{"argument_name":"variable","id":"vo:0002582","description":"aroC from Edwardsiella tarda","score":0.5615178},{"argument_name":"variable","id":"vo:0002581","description":"aroC from Edwardsiella tarda","score":0.5615178}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":3,"char_begin":628,"char_end":708},"variable_identifier":"two tailed test at n-2 degrees of freedom and 0.05 or 0.1 level of significance","value":{"value":"0.05"},"grounding":[{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.745082},{"argument_name":"variable","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7425743},{"argument_name":"variable","id":"apollosv:00000424","description":"mean with confidence interval","score":0.7402198},{"argument_name":"variable","id":"apollosv:00000425","description":"mean with standard deviation","score":0.7066522},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.704075}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":8,"block":3,"char_begin":1131,"char_end":1166},"variable_identifier":"highly significant","value":{"value":"3"},"grounding":[{"argument_name":"variable","id":"vo:0001150","description":"enhanced significant protection","score":0.728499},{"argument_name":"variable","id":"apollosv:00000286","description":"close individual places independently strategy","score":0.6825979},{"argument_name":"variable","id":"vo:0001149","description":"significant vaccine protection","score":0.6703269},{"argument_name":"variable","id":"ncit:C18725","description":"Culturally and Economically Diverse Group","score":0.6433167},{"argument_name":"variable","id":"apollosv:00000468","description":"clear infection upon vector migration","score":0.6305692}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":6,"block":9,"char_begin":7,"char_end":87},"variable_identifier":"applying the safety-critical active intervention policy","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"apollosv:00000517","description":"prioritization scheme for control measure","score":0.7690364},{"argument_name":"variable","id":"apollosv:00000292","description":"individual treatment strategy supply schedule unit of measure","score":0.7396761},{"argument_name":"variable","id":"apollosv:00000589","description":"treatment in the ICU control strategy","score":0.7299318},{"argument_name":"variable","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7293592},{"argument_name":"variable","id":"apollosv:00000063","description":"simulation of control measure participant","score":0.7240088}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3105,"char_end":3191},"variable_identifier":"total number of infections and deaths predicted on June 30th viz., 42 days","value":{"value":"2"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_deaths_new_this_week","description":"number of deaths new this week","score":0.8412262},{"argument_name":"variable","id":"cemo:number_of_cases_hospitalized_this_week","description":"number of cases hospitalized this week","score":0.8310719},{"argument_name":"variable","id":"cemo:number_of_cases_removed_from_isolation_this_week","description":"number of cases removed from isolation this week","score":0.8213837},{"argument_name":"variable","id":"cemo:total_number_of_cases_removed_from_isolation","description":"total number of cases removed from isolation","score":0.8080088},{"argument_name":"variable","id":"cemo:number_of_cases_currently_in_icu","description":"number of cases currently in icu","score":0.7985491}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":3,"block":13,"char_begin":131,"char_end":140},"variable_identifier":"gamma","variable_definition":"recovery rate, yielding the reproduction number","grounding":[{"argument_name":"description","id":"apollosv:00000043","description":"reproduction number","score":0.8135995},{"argument_name":"description","id":"cemo:average_daily_number_of_new_infections_generated_per_case_rt","description":"average daily number of new infections generated per case (rt)","score":0.8039703},{"argument_name":"description","id":"cemo:growth_rate","description":"growth rate","score":0.7972581},{"argument_name":"description","id":"cemo:effective_reproduction_number","description":"effective reproduction number","score":0.7950519},{"argument_name":"description","id":"cemo:average_rate_of_infectious_contacts","description":"average rate of infectious contacts","score":0.7790579},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","value":{"value":"0.2 1"},"grounding":[{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":22,"block":5,"char_begin":1160,"char_end":1183},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"value","id":"vo:0004933","description":"human age 1 to 2 months at vaccination","score":0.7032809},{"argument_name":"value","id":"vo:0011326","description":"CEL-170/4","score":0.6791083},{"argument_name":"value","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.6642992},{"argument_name":"value","id":"vo:0004939","description":"human age 2 to 3 years at vaccination","score":0.6589665},{"argument_name":"value","id":"vo:0004936","description":"human age 4 to 6 years at vaccination","score":0.6572067},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":23,"block":4,"char_begin":401,"char_end":451},"variable_identifier":"gamma","variable_definition":"lambda","grounding":[{"argument_name":"description","id":"vo:0000130","description":"pcDNA I/Amp DNA vaccine plasmid","score":0.5622947},{"argument_name":"description","id":"vo:0004353","description":"Duck hepatitis B DNA vaccine pcDNA I-S encoding small S proteins","score":0.5406728},{"argument_name":"description","id":"vo:0005334","description":"SII Bivalent","score":0.5363684},{"argument_name":"description","id":"vo:0004433","description":"Melanoma DNA vaccine pCR3.1-VS-HSP65-TP-GRP6-M2 encoding 6 tandem repeats of GRP","score":0.5347576},{"argument_name":"description","id":"vo:0004319","description":"Bovine herpesvirus 1 recombinant vector vaccine rLaSota/gDF encoding gD","score":0.5274865},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","value":{"value":"0.09"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"60e7da3067467f7269c05e30.pdf","page":6,"block":12,"char_begin":483,"char_end":495},"variable_identifier":"gamma","variable_definition":"set the recovery rate at gamma","grounding":[{"argument_name":"description","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7827283},{"argument_name":"description","id":"apollosv:00000101","description":"fixed control strategy start time specification","score":0.7613942},{"argument_name":"description","id":"apollosv:00000518","description":"one-way sensitivity analysis of a continuous variable","score":0.7511337},{"argument_name":"description","id":"ncit:C94941","description":"Noise Equivalent Count Rate","score":0.7493141},{"argument_name":"description","id":"ncit:C69281","description":"Rate of Administration","score":0.7395082},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","value":{"value":"0.200"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5198,"char_end":5211},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":9581,"char_end":9594},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":11514,"char_end":11527},"variable_identifier":"gamma","value":{"value":"0.171"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":13567,"char_end":13580},"variable_identifier":"gamma","value":{"value":"0.086"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4706,"char_end":4719},"variable_identifier":"gamma","value":{"value":"0.285"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":15354,"char_end":15367},"variable_identifier":"gamma","value":{"value":"0.057"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5571,"char_end":5584},"variable_identifier":"gamma","value":{"value":"0.110"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","value":{"value":"0.456"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4130,"char_end":4143},"variable_identifier":"gamma","variable_definition":"gamma","grounding":[{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"description","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"description","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"description","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":16,"block":3,"char_begin":654,"char_end":677},"variable_identifier":"gamma","variable_definition":"quarantine rate","grounding":[{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.8328103},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8214897},{"argument_name":"description","id":"ncit:C71902","description":"Quarantine","score":0.8214791},{"argument_name":"description","id":"cemo:testing_rate","description":"testing rate","score":0.7955913},{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":0.7800114},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372},{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":7,"char_begin":164,"char_end":171},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5ecbc3c4768935d2be5bd0e2.pdf","page":7,"block":10,"char_begin":809,"char_end":816},"variable_identifier":"gamma","unit_type":"M","grounding":[{"argument_name":"unit","id":"vo:0011090","description":"M Segment","score":0.736716},{"argument_name":"unit","id":"vo:0011316","description":"M protein","score":0.727854},{"argument_name":"unit","id":"vo:0011318","description":"RVFVsMgp1 M protein","score":0.7278538},{"argument_name":"unit","id":"vo:0011170","description":"M matrix protein","score":0.5772471},{"argument_name":"unit","id":"vo:0003866","description":"1 ML RabAvert 2.5 UNT/ML Injection","score":0.5666112},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","value":{"value":"1"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"6021463eea8bd37226de0b5e.pdf","page":11,"block":13,"char_begin":677,"char_end":687},"variable_identifier":"gamma","variable_definition":"infectious period","grounding":[{"argument_name":"description","id":"apollosv:00000140","description":"infectious period","score":1},{"argument_name":"description","id":"apollosv:00000016","description":"infectious period duration","score":0.9334702},{"argument_name":"description","id":"apollosv:00000017","description":"latent period duration","score":0.8083906},{"argument_name":"description","id":"apollosv:00000118","description":"latent period","score":0.8024161},{"argument_name":"description","id":"apollosv:00000449","description":"quarantine period","score":0.7959897},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":10,"block":2,"char_begin":399,"char_end":413},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616e3bd867467f7269d2f250.pdf","page":11,"block":3,"char_begin":159,"char_end":173},"variable_identifier":"gamma","value":{"value":"0.0021"},"grounding":[{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5ed7bd5b768935d2be5cd1df.pdf","page":4,"block":6,"char_begin":424,"char_end":440},"variable_identifier":"gamma","value":{"value":"1 0.1857"},"grounding":[{"argument_name":"value","id":"ncit:C43836","description":"Tokelauan","score":0.7257053},{"argument_name":"value","id":"ncit:C43874","description":"Afghanistani","score":0.7251286},{"argument_name":"value","id":"vo:0011309","description":"CP15/60","score":0.7225778},{"argument_name":"value","id":"ncit:C43827","description":"Tobagoan","score":0.7225319},{"argument_name":"value","id":"vo:0003118","description":"M-M-R I","score":0.7224179},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5f21d319a58f1dfd5210565c.pdf","page":4,"block":10,"char_begin":766,"char_end":800},"variable_identifier":"gamma","variable_definition":"parameter","grounding":[{"argument_name":"description","id":"apollosv:00000611","description":"parameter estimation model","score":0.8302639},{"argument_name":"description","id":"apollosv:00000273","description":"seasonal function parameter","score":0.7989637},{"argument_name":"description","id":"apollosv:00000477","description":"parametric probability distribution","score":0.6512609},{"argument_name":"description","id":"apollosv:00000012","description":"simulation time step value","score":0.639819},{"argument_name":"description","id":"apollosv:00000251","description":"continuous parametric probability distribution","score":0.6331666},{"argument_name":"variable","id":"apollosv:00000255","description":"gamma distribution","score":0.8174801},{"argument_name":"variable","id":"apollosv:00000078","description":"beta distribution","score":0.6763609},{"argument_name":"variable","id":"vo:0001292","description":"gamma Inulin vaccine adjuvant","score":0.5246636},{"argument_name":"variable","id":"vo:0004915","description":"vaccine specific interferon-\u03b3 immune response","score":0.5228322},{"argument_name":"variable","id":"apollosv:00000256","description":"Weibull Distribution","score":0.520372}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":3361,"char_end":3414},"variable_identifier":"period of training on 50 countries","value":{"value":"10"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_schools_with_exposure_events","description":"number of schools with exposure events","score":0.7655888},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7531376},{"argument_name":"variable","id":"apollosv:00000417","description":"life stages with duration and mortality","score":0.7313023},{"argument_name":"variable","id":"cemo:number_of_cases_with_school_exposure_events","description":"number of cases with school exposure events","score":0.7305165},{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7301008}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":4,"block":4,"char_begin":387,"char_end":392},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":139,"char_end":144},"variable_identifier":"u","value":{"value":"1"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":8,"char_begin":104,"char_end":109},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":13,"block":12,"char_begin":181,"char_end":186},"variable_identifier":"u","value":{"value":"0"},"grounding":[],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":1,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":10,"block":2,"char_begin":10,"char_end":44},"variable_identifier":"Death cases for constant","value":{"value":"10000"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_with_exposure_events","description":"number of cases with exposure events","score":0.7837561},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7793799},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7739694},{"argument_name":"variable","id":"cemo:percentage_of_cases","description":"percentage of cases","score":0.7702491},{"argument_name":"variable","id":"cemo:rate_cases_by_testing","description":"rate cases by testing","score":0.7671879}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_units","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":5,"block":0,"char_begin":362,"char_end":432},"variable_identifier":"growth and trend of Covid-19 pandemic algorithm","unit_type":"W-LSTM curve fitting","grounding":[{"argument_name":"variable","id":"cemo:number_of_cases_by_testing","description":"number of cases by testing","score":0.7303345},{"argument_name":"variable","id":"apollosv:00000498","description":"count of cases in an epidemic","score":0.7275792},{"argument_name":"variable","id":"ncit:C173721","description":"Division of Global Migration and Quarantine","score":0.7197358},{"argument_name":"variable","id":"ncit:C20165","description":"Component of the Division of Cancer Treatment and Diagnosis","score":0.7163811},{"argument_name":"variable","id":"apollosv:00000497","description":"count of disease cases","score":0.7113001},{"argument_name":"unit","id":"apollosv:00000611","description":"parameter estimation model","score":0.6236997},{"argument_name":"unit","id":"apollosv:00000256","description":"Weibull Distribution","score":0.6229447},{"argument_name":"unit","id":"apollosv:00000253","description":"continuous nonparametric probability distribution","score":0.5904258},{"argument_name":"unit","id":"apollosv:00000548","description":"Susceptible-Infected-Susceptible model","score":0.5869158},{"argument_name":"unit","id":"apollosv:00000477","description":"parametric probability distribution","score":0.582047}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"5eecd54fa58f1dfd52099ccf.pdf","page":7,"block":2,"char_begin":871,"char_end":877},"variable_identifier":"nu","variable_definition":"hospitalization rate","grounding":[{"argument_name":"description","id":"cemo:hospitalization_rate","description":"hospitalization rate","score":1},{"argument_name":"description","id":"apollosv:00000445","description":"mortality rate","score":0.8517832},{"argument_name":"description","id":"ncit:C25636","description":"Rate","score":0.8067827},{"argument_name":"description","id":"ncit:C173779","description":"Case Fatality Rate","score":0.8042514},{"argument_name":"description","id":"ncit:C25179","description":"Hospitalization","score":0.8038746},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":5251,"char_end":5261},"variable_identifier":"nu","value":{"value":"0.015"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","value":{"value":"0.027"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_description","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":9,"block":12,"char_begin":4209,"char_end":4219},"variable_identifier":"nu","variable_definition":"alpha =","grounding":[{"argument_name":"description","id":"apollosv:00000078","description":"beta distribution","score":0.626371},{"argument_name":"description","id":"apollosv:00000255","description":"gamma distribution","score":0.5458134},{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"616cf16267467f7269ccde6f.pdf","page":30,"block":1,"char_begin":394,"char_end":405},"variable_identifier":"nu","value":{"value":"0.0150"},"grounding":[{"argument_name":"variable","id":"ncit:C158198","description":"Nu Chinese","score":0.7573926},{"argument_name":"variable","id":"vo:0003109","description":"Meruvax I","score":0.6218777},{"argument_name":"variable","id":"vo:0010898","description":"E0","score":0.526215},{"argument_name":"variable","id":"vo:0005335","description":"SII B.1.617.2","score":0.5178707},{"argument_name":"variable","id":"vo:0005333","description":"SII B.1.351","score":0.5164775}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}},
                    {"metadata_type":"text_literal_value","text_extraction":{"document_reference_uid":"5eeeebb4a58f1dfd5209aecc.pdf","page":6,"block":5,"char_begin":4327,"char_end":4369},"variable_identifier":"58% of the 50 test countries","value":{"value":"25"},"grounding":[{"argument_name":"variable","id":"cemo:number_of_tests","description":"number of tests","score":0.7104326},{"argument_name":"variable","id":"cemo:percentage_of_cases_which_are_detected","description":"percentage of cases which are detected","score":0.7076355},{"argument_name":"variable","id":"cemo:rate_of_cases_with_at_least_one_comorbidity","description":"rate of cases with at least one comorbidity","score":0.7059678},{"argument_name":"variable","id":"vo:0000031","description":"MenHibrix","score":0.7057316},{"argument_name":"variable","id":"apollosv:00000339","description":"amensalism","score":0.694298}],"provenance":{"method":"embedding_similarity_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ],
                [
                    {"metadata_type":"source_code_comment","comment":"    tuple of float: A tuple representing the derivatives of the state variables with respect to time (dSdt, dIdt, dDdt, dAdt, dRdt, dTdt, dHdt, dEdt)","code_file_reference_uid":"18c3066c-64b2-3a6c-a6b2-5ea73f800f25","provenance":{"method":"heuristic_1.0","timestamp":"2022-01-01 00:00:01.0"}}
                ]
            ],
            "metadata": 1
        }
    ],
    "module_index": [

    ],
    "executables": [

    ]
}
